[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fsCK5xSUGdCQfxhwL5FYDvjDK3POIujcMrRuVcZDyruI":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":8,"nonDrugCount":8,"topConditions":11,"upcomingReadouts":32,"phaseBuckets":33,"rows":40},"Teva Pharmaceuticals USA",[4],176,false,0,9,15932,[12,15,18,21,23,26,28,30],{"name":13,"count":14},"Healthy",161,{"name":16,"count":17},"Seasonal Allergic Rhinitis",3,{"name":19,"count":20},"Acne Vulgaris",2,{"name":22,"count":20},"Actinic Keratosis",{"name":24,"count":25},"Evaluation of QTc Interval",1,{"name":27,"count":25},"Bioequivalence",{"name":29,"count":25},"Bacterial Vaginosis",{"name":31,"count":25},"Depressive Disorder",[],[34,35,36,37,38,39],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[41,65,91,109,135,153,177,203,221,247,265,292,310,336,354,381,399,424,442,474,499,517,565,595,643,688,718,763,793,828,854,895,921,959,985,1017,1047,1069,1099,1121,1148,1177,1199,1234,1262,1292,1314,1343,1365,1393,1415,1443,1465,1492,1522,1544,1573,1595,1623,1645,1673,1703,1725,1747,1776,1798,1828,1850,1878,1900,1932,1954,1984,2006,2036,2058,2088,2110,2140,2162,2192,2214,2243,2271,2293,2322,2344,2373,2395,2425,2454,2476,2506,2535,2557,2585,2607,2637,2659,2689,2711,2739,2767,2789,2818,2850,2879,2901,2929,2951,2980,3008,3030,3060,3082,3110,3136,3165,3187,3215,3237,3265,3293,3315,3344,3372,3394,3422,3444,3474,3496,3523,3551,3573,3595,3623,3645,3673,3695,3724,3746,3774,3796,3814,3836,3854,3878,3896,3914,3936,3954,3977,3995,4017,4035,4053,4071,4089,4107,4125,4147,4165,4187,4205,4223,4245,4263,4285,4308,4326,4344,4367,4385,4403,4421,4443,4461,4479,4497,4522,4540,4562,4580,4602],{"intervention":42,"totalTrials":25,"cells":43},"16 mg buprenorphine with 4 mg naloxone sublingual film",{"EARLY_PHASE1":44,"PHASE1":46,"PHASE2":48,"PHASE3":50,"PHASE4":52,"NA":63},{"trials":45,"activeCount":8},[],{"trials":47,"activeCount":8},[],{"trials":49,"activeCount":8},[],{"trials":51,"activeCount":8},[],{"trials":53,"activeCount":8},[54],{"nctId":55,"briefTitle":56,"status":57,"phases":58,"primaryCompletion":59,"completion":59,"start":60,"enrollment":8,"conditions":61,"interventions":62},"NCT04088266","An Open-Label, Single-Center Study to Evaluate the Exposure-Response Relationship Between the Plasma Drug Concentrations and the Change From Baseline in QTc at Steady State Following Once-daily Administration of CASSIPA® in Opioid Dependent Subjects.","WITHDRAWN",[38],"2020-12","2020-01",[24],[42],{"trials":64,"activeCount":8},[],{"intervention":66,"totalTrials":25,"cells":67},"Fluticasone propionate",{"EARLY_PHASE1":68,"PHASE1":70,"PHASE2":72,"PHASE3":74,"PHASE4":87,"NA":89},{"trials":69,"activeCount":8},[],{"trials":71,"activeCount":8},[],{"trials":73,"activeCount":8},[],{"trials":75,"activeCount":8},[76],{"nctId":77,"briefTitle":78,"status":79,"phases":80,"primaryCompletion":81,"completion":81,"start":82,"enrollment":83,"conditions":84,"interventions":85},"NCT02246920","Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg\u002FActuation vs. Flonase in Allergic Rhinitis Patients","TERMINATED",[37],"2014-07-14","2014-03-01",1474,[16],[66,86],"Flonase®",{"trials":88,"activeCount":8},[],{"trials":90,"activeCount":8},[],{"intervention":86,"totalTrials":25,"cells":92},{"EARLY_PHASE1":93,"PHASE1":95,"PHASE2":97,"PHASE3":99,"PHASE4":105,"NA":107},{"trials":94,"activeCount":8},[],{"trials":96,"activeCount":8},[],{"trials":98,"activeCount":8},[],{"trials":100,"activeCount":8},[101],{"nctId":77,"briefTitle":78,"status":79,"phases":102,"primaryCompletion":81,"completion":81,"start":82,"enrollment":83,"conditions":103,"interventions":104},[37],[16],[66,86],{"trials":106,"activeCount":8},[],{"trials":108,"activeCount":8},[],{"intervention":110,"totalTrials":25,"cells":111},"Trifarotene 0.005 % Topical Cream",{"EARLY_PHASE1":112,"PHASE1":114,"PHASE2":116,"PHASE3":118,"PHASE4":131,"NA":133},{"trials":113,"activeCount":8},[],{"trials":115,"activeCount":8},[],{"trials":117,"activeCount":8},[],{"trials":119,"activeCount":8},[120],{"nctId":121,"briefTitle":122,"status":123,"phases":124,"primaryCompletion":125,"completion":125,"start":126,"enrollment":127,"conditions":128,"interventions":129},"NCT05550337","Study Comparing Trifarotene Cream, 0.005% To AKLIEF ® (Trifarotene 0.005% Cream) In The Treatment Of Acne Vulgaris","COMPLETED",[37],"2023-05-09","2022-09-19",807,[19],[110,130],"AKLIEF®",{"trials":132,"activeCount":8},[],{"trials":134,"activeCount":8},[],{"intervention":130,"totalTrials":25,"cells":136},{"EARLY_PHASE1":137,"PHASE1":139,"PHASE2":141,"PHASE3":143,"PHASE4":149,"NA":151},{"trials":138,"activeCount":8},[],{"trials":140,"activeCount":8},[],{"trials":142,"activeCount":8},[],{"trials":144,"activeCount":8},[145],{"nctId":121,"briefTitle":122,"status":123,"phases":146,"primaryCompletion":125,"completion":125,"start":126,"enrollment":127,"conditions":147,"interventions":148},[37],[19],[110,130],{"trials":150,"activeCount":8},[],{"trials":152,"activeCount":8},[],{"intervention":154,"totalTrials":25,"cells":155},"Diclofenac sodium",{"EARLY_PHASE1":156,"PHASE1":158,"PHASE2":160,"PHASE3":162,"PHASE4":173,"NA":175},{"trials":157,"activeCount":8},[],{"trials":159,"activeCount":8},[],{"trials":161,"activeCount":8},[],{"trials":163,"activeCount":8},[164],{"nctId":165,"briefTitle":166,"status":123,"phases":167,"primaryCompletion":168,"completion":168,"start":169,"enrollment":170,"conditions":171,"interventions":172},"NCT02611804","A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp",[37],"2016-08","2015-10",492,[22],[154,154],{"trials":174,"activeCount":8},[],{"trials":176,"activeCount":8},[],{"intervention":178,"totalTrials":25,"cells":179},"Azelastine hydrochloride and Fluticasone propionate",{"EARLY_PHASE1":180,"PHASE1":182,"PHASE2":184,"PHASE3":186,"PHASE4":199,"NA":201},{"trials":181,"activeCount":8},[],{"trials":183,"activeCount":8},[],{"trials":185,"activeCount":8},[],{"trials":187,"activeCount":8},[188],{"nctId":189,"briefTitle":190,"status":191,"phases":192,"primaryCompletion":193,"start":194,"enrollment":195,"conditions":196,"interventions":197},"NCT02249663","Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137\u002F50 mcg Nasal Spray to Dymista™","UNKNOWN",[37],"2015-02","2014-08",1535,[16],[178,198],"Dymista™",{"trials":200,"activeCount":8},[],{"trials":202,"activeCount":8},[],{"intervention":198,"totalTrials":25,"cells":204},{"EARLY_PHASE1":205,"PHASE1":207,"PHASE2":209,"PHASE3":211,"PHASE4":217,"NA":219},{"trials":206,"activeCount":8},[],{"trials":208,"activeCount":8},[],{"trials":210,"activeCount":8},[],{"trials":212,"activeCount":8},[213],{"nctId":189,"briefTitle":190,"status":191,"phases":214,"primaryCompletion":193,"start":194,"enrollment":195,"conditions":215,"interventions":216},[37],[16],[178,198],{"trials":218,"activeCount":8},[],{"trials":220,"activeCount":8},[],{"intervention":222,"totalTrials":25,"cells":223},"TEV-45779",{"EARLY_PHASE1":224,"PHASE1":226,"PHASE2":228,"PHASE3":230,"PHASE4":243,"NA":245},{"trials":225,"activeCount":8},[],{"trials":227,"activeCount":8},[],{"trials":229,"activeCount":8},[],{"trials":231,"activeCount":8},[232],{"nctId":233,"briefTitle":234,"status":123,"phases":235,"primaryCompletion":236,"completion":236,"start":237,"enrollment":238,"conditions":239,"interventions":241},"NCT04976192","Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria",[37],"2024-04-05","2021-08-30",608,[240],"Chronic Urticaria",[222,242],"XOLAIR®",{"trials":244,"activeCount":8},[],{"trials":246,"activeCount":8},[],{"intervention":242,"totalTrials":25,"cells":248},{"EARLY_PHASE1":249,"PHASE1":251,"PHASE2":253,"PHASE3":255,"PHASE4":261,"NA":263},{"trials":250,"activeCount":8},[],{"trials":252,"activeCount":8},[],{"trials":254,"activeCount":8},[],{"trials":256,"activeCount":8},[257],{"nctId":233,"briefTitle":234,"status":123,"phases":258,"primaryCompletion":236,"completion":236,"start":237,"enrollment":238,"conditions":259,"interventions":260},[37],[240],[222,242],{"trials":262,"activeCount":8},[],{"trials":264,"activeCount":8},[],{"intervention":266,"totalTrials":25,"cells":267},"TVB-009",{"EARLY_PHASE1":268,"PHASE1":270,"PHASE2":272,"PHASE3":274,"PHASE4":288,"NA":290},{"trials":269,"activeCount":8},[],{"trials":271,"activeCount":8},[],{"trials":273,"activeCount":8},[],{"trials":275,"activeCount":8},[276],{"nctId":277,"briefTitle":278,"status":123,"phases":279,"primaryCompletion":280,"completion":281,"start":282,"enrollment":283,"conditions":284,"interventions":286},"NCT04729621","A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis",[37],"2022-12-31","2023-06-19","2021-03-22",332,[285],"Osteoporosis, Postmenopausal",[266,287],"Prolia®",{"trials":289,"activeCount":8},[],{"trials":291,"activeCount":8},[],{"intervention":287,"totalTrials":25,"cells":293},{"EARLY_PHASE1":294,"PHASE1":296,"PHASE2":298,"PHASE3":300,"PHASE4":306,"NA":308},{"trials":295,"activeCount":8},[],{"trials":297,"activeCount":8},[],{"trials":299,"activeCount":8},[],{"trials":301,"activeCount":8},[302],{"nctId":277,"briefTitle":278,"status":123,"phases":303,"primaryCompletion":280,"completion":281,"start":282,"enrollment":283,"conditions":304,"interventions":305},[37],[285],[266,287],{"trials":307,"activeCount":8},[],{"trials":309,"activeCount":8},[],{"intervention":311,"totalTrials":25,"cells":312},"Estradiol",{"EARLY_PHASE1":313,"PHASE1":315,"PHASE2":317,"PHASE3":319,"PHASE4":332,"NA":334},{"trials":314,"activeCount":8},[],{"trials":316,"activeCount":8},[],{"trials":318,"activeCount":8},[],{"trials":320,"activeCount":8},[321],{"nctId":322,"briefTitle":323,"status":123,"phases":324,"primaryCompletion":325,"completion":325,"start":326,"enrollment":327,"conditions":328,"interventions":330},"NCT05617820","Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment Of Dyspareunia in Women With Vulvur and Vaginal Atrophy",[37],"2024-03-15","2022-11-15",1050,[329],"Dyspareunia",[311,331],"Imvexxy",{"trials":333,"activeCount":8},[],{"trials":335,"activeCount":8},[],{"intervention":331,"totalTrials":25,"cells":337},{"EARLY_PHASE1":338,"PHASE1":340,"PHASE2":342,"PHASE3":344,"PHASE4":350,"NA":352},{"trials":339,"activeCount":8},[],{"trials":341,"activeCount":8},[],{"trials":343,"activeCount":8},[],{"trials":345,"activeCount":8},[346],{"nctId":322,"briefTitle":323,"status":123,"phases":347,"primaryCompletion":325,"completion":325,"start":326,"enrollment":327,"conditions":348,"interventions":349},[37],[329],[311,331],{"trials":351,"activeCount":8},[],{"trials":353,"activeCount":8},[],{"intervention":355,"totalTrials":25,"cells":356},"Tapinarof Cream 1%",{"EARLY_PHASE1":357,"PHASE1":359,"PHASE2":361,"PHASE3":363,"PHASE4":377,"NA":379},{"trials":358,"activeCount":8},[],{"trials":360,"activeCount":8},[],{"trials":362,"activeCount":8},[],{"trials":364,"activeCount":8},[365],{"nctId":366,"briefTitle":367,"status":123,"phases":368,"primaryCompletion":369,"completion":370,"start":371,"enrollment":372,"conditions":373,"interventions":375},"NCT06742957","Study Comparing Tapinarof Cream 1% To VTAMA ® (Tapinarof Cream 1%) In the Treatment of Plaque Psoriasis",[37],"2025-10-07","2025-11-12","2024-12-17",560,[374],"Plaque Type Psorisis",[355,376],"VTAMA®",{"trials":378,"activeCount":8},[],{"trials":380,"activeCount":8},[],{"intervention":376,"totalTrials":25,"cells":382},{"EARLY_PHASE1":383,"PHASE1":385,"PHASE2":387,"PHASE3":389,"PHASE4":395,"NA":397},{"trials":384,"activeCount":8},[],{"trials":386,"activeCount":8},[],{"trials":388,"activeCount":8},[],{"trials":390,"activeCount":8},[391],{"nctId":366,"briefTitle":367,"status":123,"phases":392,"primaryCompletion":369,"completion":370,"start":371,"enrollment":372,"conditions":393,"interventions":394},[37],[374],[355,376],{"trials":396,"activeCount":8},[],{"trials":398,"activeCount":8},[],{"intervention":400,"totalTrials":25,"cells":401},"Imiquimod Cream, 3.75%",{"EARLY_PHASE1":402,"PHASE1":404,"PHASE2":406,"PHASE3":408,"PHASE4":420,"NA":422},{"trials":403,"activeCount":8},[],{"trials":405,"activeCount":8},[],{"trials":407,"activeCount":8},[],{"trials":409,"activeCount":8},[410],{"nctId":411,"briefTitle":412,"status":123,"phases":413,"primaryCompletion":414,"completion":414,"start":415,"enrollment":416,"conditions":417,"interventions":418},"NCT01686152","Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis",[37],"2013-08","2012-09",589,[22],[400,419],"Zyclara®",{"trials":421,"activeCount":8},[],{"trials":423,"activeCount":8},[],{"intervention":419,"totalTrials":25,"cells":425},{"EARLY_PHASE1":426,"PHASE1":428,"PHASE2":430,"PHASE3":432,"PHASE4":438,"NA":440},{"trials":427,"activeCount":8},[],{"trials":429,"activeCount":8},[],{"trials":431,"activeCount":8},[],{"trials":433,"activeCount":8},[434],{"nctId":411,"briefTitle":412,"status":123,"phases":435,"primaryCompletion":414,"completion":414,"start":415,"enrollment":416,"conditions":436,"interventions":437},[37],[22],[400,419],{"trials":439,"activeCount":8},[],{"trials":441,"activeCount":8},[],{"intervention":443,"totalTrials":20,"cells":444},"Metronidazole",{"EARLY_PHASE1":445,"PHASE1":447,"PHASE2":458,"PHASE3":468,"PHASE4":470,"NA":472},{"trials":446,"activeCount":8},[],{"trials":448,"activeCount":8},[449],{"nctId":450,"briefTitle":451,"status":123,"phases":452,"primaryCompletion":453,"completion":454,"start":453,"enrollment":455,"conditions":456,"interventions":457},"NCT01020877","Bioavailability of Metronidazole Vaginal Gel in Healthy Subjects",[35],"2001-11","2002-01",38,[13],[443,443],{"trials":459,"activeCount":8},[460],{"nctId":461,"briefTitle":462,"status":123,"phases":463,"primaryCompletion":464,"completion":464,"start":454,"enrollment":465,"conditions":466,"interventions":467},"NCT01020396","Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis",[35,36],"2003-03",579,[29],[443,443],{"trials":469,"activeCount":8},[],{"trials":471,"activeCount":8},[],{"trials":473,"activeCount":8},[],{"intervention":475,"totalTrials":25,"cells":476},"Mometasone furoate",{"EARLY_PHASE1":477,"PHASE1":479,"PHASE2":481,"PHASE3":493,"PHASE4":495,"NA":497},{"trials":478,"activeCount":8},[],{"trials":480,"activeCount":8},[],{"trials":482,"activeCount":8},[483],{"nctId":484,"briefTitle":485,"status":123,"phases":486,"primaryCompletion":487,"completion":487,"start":488,"enrollment":489,"conditions":490,"interventions":491},"NCT01523236","Clinical Equivalence Study of Mometasone Nasal Spray, 50 Mcg\u002FActuation",[35,36],"2012-01","2011-12",800,[16],[475,492],"Nasonex®",{"trials":494,"activeCount":8},[],{"trials":496,"activeCount":8},[],{"trials":498,"activeCount":8},[],{"intervention":492,"totalTrials":25,"cells":500},{"EARLY_PHASE1":501,"PHASE1":503,"PHASE2":505,"PHASE3":511,"PHASE4":513,"NA":515},{"trials":502,"activeCount":8},[],{"trials":504,"activeCount":8},[],{"trials":506,"activeCount":8},[507],{"nctId":484,"briefTitle":485,"status":123,"phases":508,"primaryCompletion":487,"completion":487,"start":488,"enrollment":489,"conditions":509,"interventions":510},[35,36],[16],[475,492],{"trials":512,"activeCount":8},[],{"trials":514,"activeCount":8},[],{"trials":516,"activeCount":8},[],{"intervention":518,"totalTrials":519,"cells":520},"Mycophenolate Mofetil",4,{"EARLY_PHASE1":521,"PHASE1":523,"PHASE2":557,"PHASE3":559,"PHASE4":561,"NA":563},{"trials":522,"activeCount":8},[],{"trials":524,"activeCount":8},[525,535,544,551],{"nctId":526,"briefTitle":527,"status":123,"phases":528,"primaryCompletion":529,"completion":529,"start":530,"enrollment":531,"conditions":532,"interventions":533},"NCT00910663","Mycophenolate Mofetil 250 mg Capsules Under Fed Conditions",[35],"2006-11","2006-10",60,[13],[518,534],"CellCept®",{"nctId":536,"briefTitle":537,"status":123,"phases":538,"primaryCompletion":539,"completion":539,"start":540,"enrollment":541,"conditions":542,"interventions":543},"NCT00907907","Mycophenolate Mofetil Tablets Under Fasting Conditions",[35],"2006-08","2006-07",40,[13],[518,534],{"nctId":545,"briefTitle":546,"status":123,"phases":547,"primaryCompletion":529,"completion":529,"start":530,"enrollment":548,"conditions":549,"interventions":550},"NCT00911274","Mycophenolate Mofetil 250 mg Capsules Under Fasting Conditions",[35],53,[13],[518,534],{"nctId":552,"briefTitle":553,"status":123,"phases":554,"primaryCompletion":539,"completion":539,"start":539,"enrollment":541,"conditions":555,"interventions":556},"NCT00908128","Mycophenolate Mofetil Tablets Under Fed Conditions",[35],[13],[518,534],{"trials":558,"activeCount":8},[],{"trials":560,"activeCount":8},[],{"trials":562,"activeCount":8},[],{"trials":564,"activeCount":8},[],{"intervention":534,"totalTrials":519,"cells":566},{"EARLY_PHASE1":567,"PHASE1":569,"PHASE2":587,"PHASE3":589,"PHASE4":591,"NA":593},{"trials":568,"activeCount":8},[],{"trials":570,"activeCount":8},[571,575,579,583],{"nctId":526,"briefTitle":527,"status":123,"phases":572,"primaryCompletion":529,"completion":529,"start":530,"enrollment":531,"conditions":573,"interventions":574},[35],[13],[518,534],{"nctId":536,"briefTitle":537,"status":123,"phases":576,"primaryCompletion":539,"completion":539,"start":540,"enrollment":541,"conditions":577,"interventions":578},[35],[13],[518,534],{"nctId":545,"briefTitle":546,"status":123,"phases":580,"primaryCompletion":529,"completion":529,"start":530,"enrollment":548,"conditions":581,"interventions":582},[35],[13],[518,534],{"nctId":552,"briefTitle":553,"status":123,"phases":584,"primaryCompletion":539,"completion":539,"start":539,"enrollment":541,"conditions":585,"interventions":586},[35],[13],[518,534],{"trials":588,"activeCount":8},[],{"trials":590,"activeCount":8},[],{"trials":592,"activeCount":8},[],{"trials":594,"activeCount":8},[],{"intervention":596,"totalTrials":519,"cells":597},"Aricept®",{"EARLY_PHASE1":598,"PHASE1":600,"PHASE2":635,"PHASE3":637,"PHASE4":639,"NA":641},{"trials":599,"activeCount":8},[],{"trials":601,"activeCount":8},[602,612,618,627],{"nctId":603,"briefTitle":604,"status":123,"phases":605,"primaryCompletion":606,"completion":606,"start":607,"enrollment":608,"conditions":609,"interventions":610},"NCT01260922","10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Fasting Conditions.",[35],"2006-05","2006-04",26,[13],[611,596],"Donepezil Hydrochloride",{"nctId":613,"briefTitle":614,"status":123,"phases":615,"primaryCompletion":606,"completion":606,"start":607,"enrollment":608,"conditions":616,"interventions":617},"NCT01260948","10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Non-Fasting Conditions",[35],[13],[611,596],{"nctId":619,"briefTitle":620,"status":123,"phases":621,"primaryCompletion":622,"completion":622,"start":623,"enrollment":608,"conditions":624,"interventions":625},"NCT01439243","Donepezil 10 mg Tablets Under Fed Conditions",[35],"2007-07","2007-06",[13],[626,596],"Donepezil",{"nctId":628,"briefTitle":629,"status":123,"phases":630,"primaryCompletion":631,"completion":631,"start":623,"enrollment":632,"conditions":633,"interventions":634},"NCT01439230","Donepezil 10 mg Tablets Under Fasting Conditions",[35],"2007-08",36,[13],[626,596],{"trials":636,"activeCount":8},[],{"trials":638,"activeCount":8},[],{"trials":640,"activeCount":8},[],{"trials":642,"activeCount":8},[],{"intervention":644,"totalTrials":519,"cells":645},"divalproex sodium",{"EARLY_PHASE1":646,"PHASE1":648,"PHASE2":680,"PHASE3":682,"PHASE4":684,"NA":686},{"trials":647,"activeCount":8},[],{"trials":649,"activeCount":8},[650,659,668,674],{"nctId":651,"briefTitle":652,"status":123,"phases":653,"primaryCompletion":654,"completion":654,"start":654,"enrollment":655,"conditions":656,"interventions":657},"NCT00834639","Divalproex Sodium Delayed-Release Tablets Under Fasting Conditions",[35],"2003-09",24,[13],[644,658],"Depakote®",{"nctId":660,"briefTitle":661,"status":123,"phases":662,"primaryCompletion":663,"completion":663,"start":539,"enrollment":664,"conditions":665,"interventions":666},"NCT00974441","Divalproex Sodium 500 mg Extended Release Tablets Under Fasting Conditions",[35],"2006-09",48,[13],[667,658],"Divalproex Sodium",{"nctId":669,"briefTitle":670,"status":123,"phases":671,"primaryCompletion":530,"completion":530,"start":530,"enrollment":655,"conditions":672,"interventions":673},"NCT00974012","Divalproex Sodium 500 mg Extended Release Tablets Under Non-Fasting Conditions",[35],[13],[667,658],{"nctId":675,"briefTitle":676,"status":123,"phases":677,"primaryCompletion":654,"completion":654,"start":654,"enrollment":655,"conditions":678,"interventions":679},"NCT00834990","Divalproex Sodium Delayed-Release Tablets Under Non-Fasting Conditions",[35],[13],[644,658],{"trials":681,"activeCount":8},[],{"trials":683,"activeCount":8},[],{"trials":685,"activeCount":8},[],{"trials":687,"activeCount":8},[],{"intervention":658,"totalTrials":519,"cells":689},{"EARLY_PHASE1":690,"PHASE1":692,"PHASE2":710,"PHASE3":712,"PHASE4":714,"NA":716},{"trials":691,"activeCount":8},[],{"trials":693,"activeCount":8},[694,698,702,706],{"nctId":651,"briefTitle":652,"status":123,"phases":695,"primaryCompletion":654,"completion":654,"start":654,"enrollment":655,"conditions":696,"interventions":697},[35],[13],[644,658],{"nctId":660,"briefTitle":661,"status":123,"phases":699,"primaryCompletion":663,"completion":663,"start":539,"enrollment":664,"conditions":700,"interventions":701},[35],[13],[667,658],{"nctId":669,"briefTitle":670,"status":123,"phases":703,"primaryCompletion":530,"completion":530,"start":530,"enrollment":655,"conditions":704,"interventions":705},[35],[13],[667,658],{"nctId":675,"briefTitle":676,"status":123,"phases":707,"primaryCompletion":654,"completion":654,"start":654,"enrollment":655,"conditions":708,"interventions":709},[35],[13],[644,658],{"trials":711,"activeCount":8},[],{"trials":713,"activeCount":8},[],{"trials":715,"activeCount":8},[],{"trials":717,"activeCount":8},[],{"intervention":719,"totalTrials":519,"cells":720},"Levetiracetam",{"EARLY_PHASE1":721,"PHASE1":723,"PHASE2":755,"PHASE3":757,"PHASE4":759,"NA":761},{"trials":722,"activeCount":8},[],{"trials":724,"activeCount":8},[725,735,742,748],{"nctId":726,"briefTitle":727,"status":123,"phases":728,"primaryCompletion":729,"completion":729,"start":730,"enrollment":731,"conditions":732,"interventions":733},"NCT00849862","Levetiracetam 750 mg Tablets Under Fasting Conditions",[35],"2005-11","2005-10",22,[13],[719,734],"Keppra®",{"nctId":736,"briefTitle":737,"status":123,"phases":738,"primaryCompletion":739,"completion":739,"start":739,"enrollment":731,"conditions":740,"interventions":741},"NCT00859430","Levetiracetam 1000 mg Under Non-Fasting Conditions",[35],"2007-01",[13],[719,734],{"nctId":743,"briefTitle":744,"status":123,"phases":745,"primaryCompletion":729,"completion":729,"start":729,"enrollment":731,"conditions":746,"interventions":747},"NCT00849485","Levetiracetam 750 mg Tablets Under Non-Fasting Conditions",[35],[13],[719,734],{"nctId":749,"briefTitle":750,"status":123,"phases":751,"primaryCompletion":739,"completion":739,"start":739,"enrollment":752,"conditions":753,"interventions":754},"NCT00859521","Levetiracetam 1000 mg Under Fasting Conditions",[35],30,[13],[719,734],{"trials":756,"activeCount":8},[],{"trials":758,"activeCount":8},[],{"trials":760,"activeCount":8},[],{"trials":762,"activeCount":8},[],{"intervention":734,"totalTrials":519,"cells":764},{"EARLY_PHASE1":765,"PHASE1":767,"PHASE2":785,"PHASE3":787,"PHASE4":789,"NA":791},{"trials":766,"activeCount":8},[],{"trials":768,"activeCount":8},[769,773,777,781],{"nctId":726,"briefTitle":727,"status":123,"phases":770,"primaryCompletion":729,"completion":729,"start":730,"enrollment":731,"conditions":771,"interventions":772},[35],[13],[719,734],{"nctId":736,"briefTitle":737,"status":123,"phases":774,"primaryCompletion":739,"completion":739,"start":739,"enrollment":731,"conditions":775,"interventions":776},[35],[13],[719,734],{"nctId":743,"briefTitle":744,"status":123,"phases":778,"primaryCompletion":729,"completion":729,"start":729,"enrollment":731,"conditions":779,"interventions":780},[35],[13],[719,734],{"nctId":749,"briefTitle":750,"status":123,"phases":782,"primaryCompletion":739,"completion":739,"start":739,"enrollment":752,"conditions":783,"interventions":784},[35],[13],[719,734],{"trials":786,"activeCount":8},[],{"trials":788,"activeCount":8},[],{"trials":790,"activeCount":8},[],{"trials":792,"activeCount":8},[],{"intervention":794,"totalTrials":17,"cells":795},"Ramipril 10 mg",{"EARLY_PHASE1":796,"PHASE1":798,"PHASE2":820,"PHASE3":822,"PHASE4":824,"NA":826},{"trials":797,"activeCount":8},[],{"trials":799,"activeCount":8},[800,809,815],{"nctId":801,"briefTitle":802,"status":123,"phases":803,"primaryCompletion":804,"completion":804,"start":805,"enrollment":541,"conditions":806,"interventions":807},"NCT00829530","Ramipril 10 mg Capsule in Healthy Subjects Under Fed Conditions",[35],"2004-10","2004-08",[13],[794,808],"Altace® 10 mg",{"nctId":810,"briefTitle":811,"status":123,"phases":812,"primaryCompletion":804,"completion":804,"start":805,"enrollment":541,"conditions":813,"interventions":814},"NCT00828321","Ramipril 10 mg Capsule in Healthy Subjects Under Fasting Conditions",[35],[13],[794,808],{"nctId":816,"briefTitle":811,"status":123,"phases":817,"primaryCompletion":804,"completion":804,"start":805,"enrollment":541,"conditions":818,"interventions":819},"NCT00829452",[35],[13],[794,808],{"trials":821,"activeCount":8},[],{"trials":823,"activeCount":8},[],{"trials":825,"activeCount":8},[],{"trials":827,"activeCount":8},[],{"intervention":808,"totalTrials":17,"cells":829},{"EARLY_PHASE1":830,"PHASE1":832,"PHASE2":846,"PHASE3":848,"PHASE4":850,"NA":852},{"trials":831,"activeCount":8},[],{"trials":833,"activeCount":8},[834,838,842],{"nctId":801,"briefTitle":802,"status":123,"phases":835,"primaryCompletion":804,"completion":804,"start":805,"enrollment":541,"conditions":836,"interventions":837},[35],[13],[794,808],{"nctId":810,"briefTitle":811,"status":123,"phases":839,"primaryCompletion":804,"completion":804,"start":805,"enrollment":541,"conditions":840,"interventions":841},[35],[13],[794,808],{"nctId":816,"briefTitle":811,"status":123,"phases":843,"primaryCompletion":804,"completion":804,"start":805,"enrollment":541,"conditions":844,"interventions":845},[35],[13],[794,808],{"trials":847,"activeCount":8},[],{"trials":849,"activeCount":8},[],{"trials":851,"activeCount":8},[],{"trials":853,"activeCount":8},[],{"intervention":855,"totalTrials":17,"cells":856},"Lansoprazole",{"EARLY_PHASE1":857,"PHASE1":859,"PHASE2":887,"PHASE3":889,"PHASE4":891,"NA":893},{"trials":858,"activeCount":8},[],{"trials":860,"activeCount":8},[861,870,877],{"nctId":862,"briefTitle":863,"status":123,"phases":864,"primaryCompletion":654,"completion":654,"start":865,"enrollment":866,"conditions":867,"interventions":868},"NCT01046084","Lansoprazole 30 mg DR Capsule Replicate Food Study",[35],"2003-08",50,[13],[855,869],"Prevacid®",{"nctId":871,"briefTitle":872,"status":123,"phases":873,"primaryCompletion":874,"completion":874,"start":874,"enrollment":866,"conditions":875,"interventions":876},"NCT01046253","Lansoprazole 30 mg DR Capsule Fasting Replicate Sprinkle Study",[35],"2004-01",[13],[855,869],{"nctId":878,"briefTitle":879,"status":123,"phases":880,"primaryCompletion":881,"completion":882,"start":883,"enrollment":884,"conditions":885,"interventions":886},"NCT01045967","Lansoprazole 30 mg DR Capsule Fasting Study",[35],"2004-06","2004-07","2004-05",56,[13],[855,869],{"trials":888,"activeCount":8},[],{"trials":890,"activeCount":8},[],{"trials":892,"activeCount":8},[],{"trials":894,"activeCount":8},[],{"intervention":869,"totalTrials":17,"cells":896},{"EARLY_PHASE1":897,"PHASE1":899,"PHASE2":913,"PHASE3":915,"PHASE4":917,"NA":919},{"trials":898,"activeCount":8},[],{"trials":900,"activeCount":8},[901,905,909],{"nctId":862,"briefTitle":863,"status":123,"phases":902,"primaryCompletion":654,"completion":654,"start":865,"enrollment":866,"conditions":903,"interventions":904},[35],[13],[855,869],{"nctId":871,"briefTitle":872,"status":123,"phases":906,"primaryCompletion":874,"completion":874,"start":874,"enrollment":866,"conditions":907,"interventions":908},[35],[13],[855,869],{"nctId":878,"briefTitle":879,"status":123,"phases":910,"primaryCompletion":881,"completion":882,"start":883,"enrollment":884,"conditions":911,"interventions":912},[35],[13],[855,869],{"trials":914,"activeCount":8},[],{"trials":916,"activeCount":8},[],{"trials":918,"activeCount":8},[],{"trials":920,"activeCount":8},[],{"intervention":922,"totalTrials":17,"cells":923},"Venlafaxine Hydrochloride",{"EARLY_PHASE1":924,"PHASE1":926,"PHASE2":951,"PHASE3":953,"PHASE4":955,"NA":957},{"trials":925,"activeCount":8},[],{"trials":927,"activeCount":8},[928,938,945],{"nctId":929,"briefTitle":930,"status":123,"phases":931,"primaryCompletion":932,"completion":932,"start":933,"enrollment":934,"conditions":935,"interventions":936},"NCT01282801","Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed Conditions",[35],"2002-10","2002-09",18,[13],[922,937],"Effexor® XR",{"nctId":939,"briefTitle":940,"status":123,"phases":941,"primaryCompletion":464,"completion":464,"start":942,"enrollment":655,"conditions":943,"interventions":944},"NCT01282814","Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Sprinkle Study",[35],"2003-02",[13],[922,937],{"nctId":946,"briefTitle":947,"status":123,"phases":948,"primaryCompletion":932,"completion":932,"start":933,"enrollment":655,"conditions":949,"interventions":950},"NCT01260896","Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fasting Conditions",[35],[13],[922,937],{"trials":952,"activeCount":8},[],{"trials":954,"activeCount":8},[],{"trials":956,"activeCount":8},[],{"trials":958,"activeCount":8},[],{"intervention":937,"totalTrials":17,"cells":960},{"EARLY_PHASE1":961,"PHASE1":963,"PHASE2":977,"PHASE3":979,"PHASE4":981,"NA":983},{"trials":962,"activeCount":8},[],{"trials":964,"activeCount":8},[965,969,973],{"nctId":929,"briefTitle":930,"status":123,"phases":966,"primaryCompletion":932,"completion":932,"start":933,"enrollment":934,"conditions":967,"interventions":968},[35],[13],[922,937],{"nctId":939,"briefTitle":940,"status":123,"phases":970,"primaryCompletion":464,"completion":464,"start":942,"enrollment":655,"conditions":971,"interventions":972},[35],[13],[922,937],{"nctId":946,"briefTitle":947,"status":123,"phases":974,"primaryCompletion":932,"completion":932,"start":933,"enrollment":655,"conditions":975,"interventions":976},[35],[13],[922,937],{"trials":978,"activeCount":8},[],{"trials":980,"activeCount":8},[],{"trials":982,"activeCount":8},[],{"trials":984,"activeCount":8},[],{"intervention":986,"totalTrials":20,"cells":987},"Norethindrone\u002FEthinyl Estradiol",{"EARLY_PHASE1":988,"PHASE1":990,"PHASE2":1009,"PHASE3":1011,"PHASE4":1013,"NA":1015},{"trials":989,"activeCount":8},[],{"trials":991,"activeCount":8},[992,1001],{"nctId":993,"briefTitle":994,"status":123,"phases":995,"primaryCompletion":996,"completion":996,"start":997,"enrollment":632,"conditions":998,"interventions":999},"NCT01344369","Norethindrone\u002FEthinyl Estradiol 0.4 mg\u002F35 Mcg Chewable Tablets Under Non-Fasted Conditions",[35],"2008-09","2008-08",[13],[986,1000],"FEMCON® Fe",{"nctId":1002,"briefTitle":1003,"status":123,"phases":1004,"primaryCompletion":739,"completion":739,"start":1005,"enrollment":632,"conditions":1006,"interventions":1007},"NCT01340625","Norethindrone\u002FEthinyl Estradiol 0.4 mg\u002F35 Mcg Chewable Tablets Under Fasting Conditions",[35],"2006-12",[27],[986,1008],"Ovcon® 35 Fe",{"trials":1010,"activeCount":8},[],{"trials":1012,"activeCount":8},[],{"trials":1014,"activeCount":8},[],{"trials":1016,"activeCount":8},[],{"intervention":1018,"totalTrials":20,"cells":1019},"Benazepril HCl 40 mg",{"EARLY_PHASE1":1020,"PHASE1":1022,"PHASE2":1039,"PHASE3":1041,"PHASE4":1043,"NA":1045},{"trials":1021,"activeCount":8},[],{"trials":1023,"activeCount":8},[1024,1033],{"nctId":1025,"briefTitle":1026,"status":123,"phases":1027,"primaryCompletion":1028,"completion":1028,"start":1029,"enrollment":541,"conditions":1030,"interventions":1031},"NCT00836576","Benazepril HCl 40 mg Tablets, Fasting",[35],"2001-03","2001-02",[13],[1018,1032],"Lotensin® 40 mg",{"nctId":1034,"briefTitle":1035,"status":123,"phases":1036,"primaryCompletion":1028,"completion":1028,"start":1028,"enrollment":541,"conditions":1037,"interventions":1038},"NCT00836537","Benazepril HCl 40 mg Tablets, Fed",[35],[13],[1018,1032],{"trials":1040,"activeCount":8},[],{"trials":1042,"activeCount":8},[],{"trials":1044,"activeCount":8},[],{"trials":1046,"activeCount":8},[],{"intervention":1032,"totalTrials":20,"cells":1048},{"EARLY_PHASE1":1049,"PHASE1":1051,"PHASE2":1061,"PHASE3":1063,"PHASE4":1065,"NA":1067},{"trials":1050,"activeCount":8},[],{"trials":1052,"activeCount":8},[1053,1057],{"nctId":1025,"briefTitle":1026,"status":123,"phases":1054,"primaryCompletion":1028,"completion":1028,"start":1029,"enrollment":541,"conditions":1055,"interventions":1056},[35],[13],[1018,1032],{"nctId":1034,"briefTitle":1035,"status":123,"phases":1058,"primaryCompletion":1028,"completion":1028,"start":1028,"enrollment":541,"conditions":1059,"interventions":1060},[35],[13],[1018,1032],{"trials":1062,"activeCount":8},[],{"trials":1064,"activeCount":8},[],{"trials":1066,"activeCount":8},[],{"trials":1068,"activeCount":8},[],{"intervention":1070,"totalTrials":20,"cells":1071},"Fluoxetine Hydrochloride",{"EARLY_PHASE1":1072,"PHASE1":1074,"PHASE2":1091,"PHASE3":1093,"PHASE4":1095,"NA":1097},{"trials":1073,"activeCount":8},[],{"trials":1075,"activeCount":8},[1076,1085],{"nctId":1077,"briefTitle":1078,"status":123,"phases":1079,"primaryCompletion":1080,"completion":1080,"start":1081,"enrollment":608,"conditions":1082,"interventions":1083},"NCT01247285","90 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting Conditions",[35],"2001-07","2001-05",[13],[1070,1084],"PROZAC WEEKLY®",{"nctId":1086,"briefTitle":1087,"status":123,"phases":1088,"primaryCompletion":1080,"completion":1080,"start":1081,"enrollment":608,"conditions":1089,"interventions":1090},"NCT01247272","90 mg Fluoxetine Hydrochloride Capsules Under Fasting Conditions",[35],[13],[1070,1084],{"trials":1092,"activeCount":8},[],{"trials":1094,"activeCount":8},[],{"trials":1096,"activeCount":8},[],{"trials":1098,"activeCount":8},[],{"intervention":1084,"totalTrials":20,"cells":1100},{"EARLY_PHASE1":1101,"PHASE1":1103,"PHASE2":1113,"PHASE3":1115,"PHASE4":1117,"NA":1119},{"trials":1102,"activeCount":8},[],{"trials":1104,"activeCount":8},[1105,1109],{"nctId":1077,"briefTitle":1078,"status":123,"phases":1106,"primaryCompletion":1080,"completion":1080,"start":1081,"enrollment":608,"conditions":1107,"interventions":1108},[35],[13],[1070,1084],{"nctId":1086,"briefTitle":1087,"status":123,"phases":1110,"primaryCompletion":1080,"completion":1080,"start":1081,"enrollment":608,"conditions":1111,"interventions":1112},[35],[13],[1070,1084],{"trials":1114,"activeCount":8},[],{"trials":1116,"activeCount":8},[],{"trials":1118,"activeCount":8},[],{"trials":1120,"activeCount":8},[],{"intervention":1122,"totalTrials":20,"cells":1123},"Dexmethylphenidate Hydrochloride",{"EARLY_PHASE1":1124,"PHASE1":1126,"PHASE2":1140,"PHASE3":1142,"PHASE4":1144,"NA":1146},{"trials":1125,"activeCount":8},[],{"trials":1127,"activeCount":8},[1128,1134],{"nctId":1129,"briefTitle":1130,"status":123,"phases":1131,"primaryCompletion":881,"completion":881,"start":881,"enrollment":655,"conditions":1132,"interventions":1133},"NCT00829712","Dexmethylphenidate Hydrochloride Tablets Under Fasting Conditions",[35],[13],[1122,1122],{"nctId":1135,"briefTitle":1136,"status":123,"phases":1137,"primaryCompletion":881,"completion":881,"start":881,"enrollment":655,"conditions":1138,"interventions":1139},"NCT00829673","Dexmethylphenidate Hydrochloride Tablets Under Non-Fasting Conditions",[35],[13],[1122,1122],{"trials":1141,"activeCount":8},[],{"trials":1143,"activeCount":8},[],{"trials":1145,"activeCount":8},[],{"trials":1147,"activeCount":8},[],{"intervention":1149,"totalTrials":20,"cells":1150},"Cefprozil for oral suspension 250 mg\u002F5 mL",{"EARLY_PHASE1":1151,"PHASE1":1153,"PHASE2":1169,"PHASE3":1171,"PHASE4":1173,"NA":1175},{"trials":1152,"activeCount":8},[],{"trials":1154,"activeCount":8},[1155,1162],{"nctId":1156,"briefTitle":1157,"status":123,"phases":1158,"primaryCompletion":883,"completion":883,"start":883,"enrollment":608,"conditions":1159,"interventions":1160},"NCT00835354","Cefprozil for Oral Suspension 250 mg\u002F5 mL, Non-fasting",[35],[13],[1149,1161],"CEFZIL® for Oral Suspension 250 mg\u002F5mL",{"nctId":1163,"briefTitle":1164,"status":123,"phases":1165,"primaryCompletion":1166,"completion":1166,"start":1166,"enrollment":608,"conditions":1167,"interventions":1168},"NCT00835614","Cefprozil for Oral Suspension 250 mg\u002F5 mL, Fasting",[35],"2004-04",[13],[1149,1161],{"trials":1170,"activeCount":8},[],{"trials":1172,"activeCount":8},[],{"trials":1174,"activeCount":8},[],{"trials":1176,"activeCount":8},[],{"intervention":1161,"totalTrials":20,"cells":1178},{"EARLY_PHASE1":1179,"PHASE1":1181,"PHASE2":1191,"PHASE3":1193,"PHASE4":1195,"NA":1197},{"trials":1180,"activeCount":8},[],{"trials":1182,"activeCount":8},[1183,1187],{"nctId":1156,"briefTitle":1157,"status":123,"phases":1184,"primaryCompletion":883,"completion":883,"start":883,"enrollment":608,"conditions":1185,"interventions":1186},[35],[13],[1149,1161],{"nctId":1163,"briefTitle":1164,"status":123,"phases":1188,"primaryCompletion":1166,"completion":1166,"start":1166,"enrollment":608,"conditions":1189,"interventions":1190},[35],[13],[1149,1161],{"trials":1192,"activeCount":8},[],{"trials":1194,"activeCount":8},[],{"trials":1196,"activeCount":8},[],{"trials":1198,"activeCount":8},[],{"intervention":1200,"totalTrials":20,"cells":1201},"Leflunomide 20 mg",{"EARLY_PHASE1":1202,"PHASE1":1204,"PHASE2":1226,"PHASE3":1228,"PHASE4":1230,"NA":1232},{"trials":1203,"activeCount":8},[],{"trials":1205,"activeCount":8},[1206,1216],{"nctId":1207,"briefTitle":1208,"status":123,"phases":1209,"primaryCompletion":1210,"completion":1210,"start":1211,"enrollment":1212,"conditions":1213,"interventions":1214},"NCT00834405","Leflunomide 20 mg Tablets, Non-Fasting",[35],"2002-05","2002-04",37,[13],[1215,1200],"ARAVA® 20 mg",{"nctId":1217,"briefTitle":1218,"status":123,"phases":1219,"primaryCompletion":1220,"completion":1220,"start":1221,"enrollment":1222,"conditions":1223,"interventions":1224},"NCT00834418","Leflunomide 20 mg Tablets Under Fasting Conditions",[35],"2002-07","2002-06",84,[13],[1200,1225],"ARAVA™ 20 mg",{"trials":1227,"activeCount":8},[],{"trials":1229,"activeCount":8},[],{"trials":1231,"activeCount":8},[],{"trials":1233,"activeCount":8},[],{"intervention":1235,"totalTrials":20,"cells":1236},"Risperidone",{"EARLY_PHASE1":1237,"PHASE1":1239,"PHASE2":1254,"PHASE3":1256,"PHASE4":1258,"NA":1260},{"trials":1238,"activeCount":8},[],{"trials":1240,"activeCount":8},[1241,1248],{"nctId":1242,"briefTitle":1243,"status":123,"phases":1244,"primaryCompletion":1080,"completion":882,"start":1245,"enrollment":752,"conditions":1246,"interventions":1247},"NCT00830349","Risperidone 1 mg Tablet in Healthy Subjects Under Fasting Conditions",[35],"2001-06",[13],[1235,1235],{"nctId":1249,"briefTitle":1250,"status":123,"phases":1251,"primaryCompletion":1080,"completion":1080,"start":1245,"enrollment":655,"conditions":1252,"interventions":1253},"NCT00829894","Risperidone 1 mg Tablets Dosed in Healthy Subjects Under Fed Conditions",[35],[13],[1235,1235],{"trials":1255,"activeCount":8},[],{"trials":1257,"activeCount":8},[],{"trials":1259,"activeCount":8},[],{"trials":1261,"activeCount":8},[],{"intervention":1263,"totalTrials":20,"cells":1264},"BUSPAR® 30 mg",{"EARLY_PHASE1":1265,"PHASE1":1267,"PHASE2":1284,"PHASE3":1286,"PHASE4":1288,"NA":1290},{"trials":1266,"activeCount":8},[],{"trials":1268,"activeCount":8},[1269,1277],{"nctId":1270,"briefTitle":1271,"status":123,"phases":1272,"primaryCompletion":1273,"completion":1273,"start":1273,"enrollment":655,"conditions":1274,"interventions":1275},"NCT00840398","Buspirone Hydrochloride 30mg Tablets, Non-Fasting",[35],"2001-12",[13],[1263,1276],"Buspirone Hydrochloride 30 mg",{"nctId":1278,"briefTitle":1279,"status":123,"phases":1280,"primaryCompletion":1273,"completion":1211,"start":1273,"enrollment":1281,"conditions":1282,"interventions":1283},"NCT00840606","Buspirone Hydrochloride 30mg Tablets, Fasting",[35],70,[13],[1263,1276],{"trials":1285,"activeCount":8},[],{"trials":1287,"activeCount":8},[],{"trials":1289,"activeCount":8},[],{"trials":1291,"activeCount":8},[],{"intervention":1276,"totalTrials":20,"cells":1293},{"EARLY_PHASE1":1294,"PHASE1":1296,"PHASE2":1306,"PHASE3":1308,"PHASE4":1310,"NA":1312},{"trials":1295,"activeCount":8},[],{"trials":1297,"activeCount":8},[1298,1302],{"nctId":1270,"briefTitle":1271,"status":123,"phases":1299,"primaryCompletion":1273,"completion":1273,"start":1273,"enrollment":655,"conditions":1300,"interventions":1301},[35],[13],[1263,1276],{"nctId":1278,"briefTitle":1279,"status":123,"phases":1303,"primaryCompletion":1273,"completion":1211,"start":1273,"enrollment":1281,"conditions":1304,"interventions":1305},[35],[13],[1263,1276],{"trials":1307,"activeCount":8},[],{"trials":1309,"activeCount":8},[],{"trials":1311,"activeCount":8},[],{"trials":1313,"activeCount":8},[],{"intervention":1315,"totalTrials":20,"cells":1316},"Glimepiride 4 mg",{"EARLY_PHASE1":1317,"PHASE1":1319,"PHASE2":1335,"PHASE3":1337,"PHASE4":1339,"NA":1341},{"trials":1318,"activeCount":8},[],{"trials":1320,"activeCount":8},[1321,1329],{"nctId":1322,"briefTitle":1323,"status":123,"phases":1324,"primaryCompletion":464,"completion":464,"start":464,"enrollment":1325,"conditions":1326,"interventions":1327},"NCT00835172","Glimepiride 4 mg Tablets Under Non-Fasting Conditions",[35],32,[13],[1315,1328],"AMARYL® 4 mg",{"nctId":1330,"briefTitle":1331,"status":123,"phases":1332,"primaryCompletion":464,"completion":464,"start":942,"enrollment":1325,"conditions":1333,"interventions":1334},"NCT00834340","Glimepiride 4 mg Tablets Under Fasting Conditions",[35],[13],[1315,1328],{"trials":1336,"activeCount":8},[],{"trials":1338,"activeCount":8},[],{"trials":1340,"activeCount":8},[],{"trials":1342,"activeCount":8},[],{"intervention":1328,"totalTrials":20,"cells":1344},{"EARLY_PHASE1":1345,"PHASE1":1347,"PHASE2":1357,"PHASE3":1359,"PHASE4":1361,"NA":1363},{"trials":1346,"activeCount":8},[],{"trials":1348,"activeCount":8},[1349,1353],{"nctId":1322,"briefTitle":1323,"status":123,"phases":1350,"primaryCompletion":464,"completion":464,"start":464,"enrollment":1325,"conditions":1351,"interventions":1352},[35],[13],[1315,1328],{"nctId":1330,"briefTitle":1331,"status":123,"phases":1354,"primaryCompletion":464,"completion":464,"start":942,"enrollment":1325,"conditions":1355,"interventions":1356},[35],[13],[1315,1328],{"trials":1358,"activeCount":8},[],{"trials":1360,"activeCount":8},[],{"trials":1362,"activeCount":8},[],{"trials":1364,"activeCount":8},[],{"intervention":1366,"totalTrials":20,"cells":1367},"Carvedilol 25 mg",{"EARLY_PHASE1":1368,"PHASE1":1370,"PHASE2":1385,"PHASE3":1387,"PHASE4":1389,"NA":1391},{"trials":1369,"activeCount":8},[],{"trials":1371,"activeCount":8},[1372,1379],{"nctId":1373,"briefTitle":1374,"status":123,"phases":1375,"primaryCompletion":1273,"completion":1273,"start":1273,"enrollment":632,"conditions":1376,"interventions":1377},"NCT00834795","Carvedilol 25 mg in 36 Fasted, Healthy, Adult Subjects",[35],[13],[1366,1378],"COREG® 25 mg",{"nctId":1380,"briefTitle":1381,"status":123,"phases":1382,"primaryCompletion":1273,"completion":1273,"start":1273,"enrollment":655,"conditions":1383,"interventions":1384},"NCT00834873","Carvedilol (25 mg) in 24 Fed, Healthy, Adult Subjects",[35],[13],[1366,1378],{"trials":1386,"activeCount":8},[],{"trials":1388,"activeCount":8},[],{"trials":1390,"activeCount":8},[],{"trials":1392,"activeCount":8},[],{"intervention":1378,"totalTrials":20,"cells":1394},{"EARLY_PHASE1":1395,"PHASE1":1397,"PHASE2":1407,"PHASE3":1409,"PHASE4":1411,"NA":1413},{"trials":1396,"activeCount":8},[],{"trials":1398,"activeCount":8},[1399,1403],{"nctId":1373,"briefTitle":1374,"status":123,"phases":1400,"primaryCompletion":1273,"completion":1273,"start":1273,"enrollment":632,"conditions":1401,"interventions":1402},[35],[13],[1366,1378],{"nctId":1380,"briefTitle":1381,"status":123,"phases":1404,"primaryCompletion":1273,"completion":1273,"start":1273,"enrollment":655,"conditions":1405,"interventions":1406},[35],[13],[1366,1378],{"trials":1408,"activeCount":8},[],{"trials":1410,"activeCount":8},[],{"trials":1412,"activeCount":8},[],{"trials":1414,"activeCount":8},[],{"intervention":1416,"totalTrials":20,"cells":1417},"5 mg\u002F500 mg METAGLIP™",{"EARLY_PHASE1":1418,"PHASE1":1420,"PHASE2":1435,"PHASE3":1437,"PHASE4":1439,"NA":1441},{"trials":1419,"activeCount":8},[],{"trials":1421,"activeCount":8},[1422,1429],{"nctId":1423,"briefTitle":1424,"status":123,"phases":1425,"primaryCompletion":881,"completion":881,"start":881,"enrollment":541,"conditions":1426,"interventions":1427},"NCT00834587","5 mg Glipizide\u002F500 mg Metformin Hydrochloride Tablets, Non-Fasting",[35],[13],[1416,1428],"5 mg\u002F500 mg Glipizide Metformin Hydrochloride",{"nctId":1430,"briefTitle":1431,"status":123,"phases":1432,"primaryCompletion":881,"completion":881,"start":881,"enrollment":541,"conditions":1433,"interventions":1434},"NCT00835497","5 mg Glipizide\u002F500 mg Metformin Hydrochloride Tablets, Fasting",[35],[13],[1428,1416],{"trials":1436,"activeCount":8},[],{"trials":1438,"activeCount":8},[],{"trials":1440,"activeCount":8},[],{"trials":1442,"activeCount":8},[],{"intervention":1428,"totalTrials":20,"cells":1444},{"EARLY_PHASE1":1445,"PHASE1":1447,"PHASE2":1457,"PHASE3":1459,"PHASE4":1461,"NA":1463},{"trials":1446,"activeCount":8},[],{"trials":1448,"activeCount":8},[1449,1453],{"nctId":1423,"briefTitle":1424,"status":123,"phases":1450,"primaryCompletion":881,"completion":881,"start":881,"enrollment":541,"conditions":1451,"interventions":1452},[35],[13],[1416,1428],{"nctId":1430,"briefTitle":1431,"status":123,"phases":1454,"primaryCompletion":881,"completion":881,"start":881,"enrollment":541,"conditions":1455,"interventions":1456},[35],[13],[1428,1416],{"trials":1458,"activeCount":8},[],{"trials":1460,"activeCount":8},[],{"trials":1462,"activeCount":8},[],{"trials":1464,"activeCount":8},[],{"intervention":1466,"totalTrials":20,"cells":1467},"Doxycycline Monohydrate",{"EARLY_PHASE1":1468,"PHASE1":1470,"PHASE2":1484,"PHASE3":1486,"PHASE4":1488,"NA":1490},{"trials":1469,"activeCount":8},[],{"trials":1471,"activeCount":8},[1472,1478],{"nctId":1473,"briefTitle":1474,"status":123,"phases":1475,"primaryCompletion":530,"completion":530,"start":530,"enrollment":752,"conditions":1476,"interventions":1477},"NCT00829764","Doxycycline Monohydrate 25 mg (5mL) Oral Suspension Under Fasting Conditions",[35],[13],[1466,1466],{"nctId":1479,"briefTitle":1480,"status":123,"phases":1481,"primaryCompletion":530,"completion":530,"start":530,"enrollment":752,"conditions":1482,"interventions":1483},"NCT00829790","Doxycycline Monohydrate 25 mg (5mL) Oral Suspension Under Fed Conditions",[35],[13],[1466,1466],{"trials":1485,"activeCount":8},[],{"trials":1487,"activeCount":8},[],{"trials":1489,"activeCount":8},[],{"trials":1491,"activeCount":8},[],{"intervention":1493,"totalTrials":20,"cells":1494},"Sumatriptan Succinate",{"EARLY_PHASE1":1495,"PHASE1":1497,"PHASE2":1514,"PHASE3":1516,"PHASE4":1518,"NA":1520},{"trials":1496,"activeCount":8},[],{"trials":1498,"activeCount":8},[1499,1507],{"nctId":1500,"briefTitle":1501,"status":123,"phases":1502,"primaryCompletion":464,"completion":464,"start":464,"enrollment":1503,"conditions":1504,"interventions":1505},"NCT00847405","Sumatriptan Succinate 100 mg Tablets Under Fasting Conditions",[35],28,[13],[1493,1506],"Imitrex®",{"nctId":1508,"briefTitle":1509,"status":123,"phases":1510,"primaryCompletion":1511,"completion":804,"start":805,"enrollment":1503,"conditions":1512,"interventions":1513},"NCT00846885","Sumatriptan Succinate 100 mg Tablets Under Non-Fasting Conditions",[35],"2004-09",[13],[1493,1506],{"trials":1515,"activeCount":8},[],{"trials":1517,"activeCount":8},[],{"trials":1519,"activeCount":8},[],{"trials":1521,"activeCount":8},[],{"intervention":1506,"totalTrials":20,"cells":1523},{"EARLY_PHASE1":1524,"PHASE1":1526,"PHASE2":1536,"PHASE3":1538,"PHASE4":1540,"NA":1542},{"trials":1525,"activeCount":8},[],{"trials":1527,"activeCount":8},[1528,1532],{"nctId":1500,"briefTitle":1501,"status":123,"phases":1529,"primaryCompletion":464,"completion":464,"start":464,"enrollment":1503,"conditions":1530,"interventions":1531},[35],[13],[1493,1506],{"nctId":1508,"briefTitle":1509,"status":123,"phases":1533,"primaryCompletion":1511,"completion":804,"start":805,"enrollment":1503,"conditions":1534,"interventions":1535},[35],[13],[1493,1506],{"trials":1537,"activeCount":8},[],{"trials":1539,"activeCount":8},[],{"trials":1541,"activeCount":8},[],{"trials":1543,"activeCount":8},[],{"intervention":1545,"totalTrials":20,"cells":1546},"Venlafaxine 25 mg",{"EARLY_PHASE1":1547,"PHASE1":1549,"PHASE2":1565,"PHASE3":1567,"PHASE4":1569,"NA":1571},{"trials":1548,"activeCount":8},[],{"trials":1550,"activeCount":8},[1551,1559],{"nctId":1552,"briefTitle":1553,"status":123,"phases":1554,"primaryCompletion":1555,"completion":1555,"start":1555,"enrollment":934,"conditions":1556,"interventions":1557},"NCT00834249","Venlafaxine 25 mg Tablets Under Non-Fasting Conditions",[35],"2002-12",[13],[1545,1558],"Effexor® 25 mg",{"nctId":1560,"briefTitle":1561,"status":123,"phases":1562,"primaryCompletion":1555,"completion":1555,"start":1555,"enrollment":752,"conditions":1563,"interventions":1564},"NCT00834964","Venlafaxine 25 mg Tablets Under Fasting Conditions",[35],[13],[1545,1558],{"trials":1566,"activeCount":8},[],{"trials":1568,"activeCount":8},[],{"trials":1570,"activeCount":8},[],{"trials":1572,"activeCount":8},[],{"intervention":1558,"totalTrials":20,"cells":1574},{"EARLY_PHASE1":1575,"PHASE1":1577,"PHASE2":1587,"PHASE3":1589,"PHASE4":1591,"NA":1593},{"trials":1576,"activeCount":8},[],{"trials":1578,"activeCount":8},[1579,1583],{"nctId":1552,"briefTitle":1553,"status":123,"phases":1580,"primaryCompletion":1555,"completion":1555,"start":1555,"enrollment":934,"conditions":1581,"interventions":1582},[35],[13],[1545,1558],{"nctId":1560,"briefTitle":1561,"status":123,"phases":1584,"primaryCompletion":1555,"completion":1555,"start":1555,"enrollment":752,"conditions":1585,"interventions":1586},[35],[13],[1545,1558],{"trials":1588,"activeCount":8},[],{"trials":1590,"activeCount":8},[],{"trials":1592,"activeCount":8},[],{"trials":1594,"activeCount":8},[],{"intervention":1596,"totalTrials":20,"cells":1597},"Cefadroxil 500 mg",{"EARLY_PHASE1":1598,"PHASE1":1600,"PHASE2":1615,"PHASE3":1617,"PHASE4":1619,"NA":1621},{"trials":1599,"activeCount":8},[],{"trials":1601,"activeCount":8},[1602,1609],{"nctId":1603,"briefTitle":1604,"status":123,"phases":1605,"primaryCompletion":804,"completion":804,"start":1511,"enrollment":608,"conditions":1606,"interventions":1607},"NCT00834275","Cefadroxil 500 mg Capsules Under Fasting Conditions",[35],[13],[1596,1608],"DURICEF® capsules 500 mg",{"nctId":1610,"briefTitle":1611,"status":123,"phases":1612,"primaryCompletion":804,"completion":804,"start":1511,"enrollment":608,"conditions":1613,"interventions":1614},"NCT00835081","Cefadroxil 500 mg Capsules in Normal Healthy Non-Smoking Male and Female Subjects.",[35],[13],[1596,1608],{"trials":1616,"activeCount":8},[],{"trials":1618,"activeCount":8},[],{"trials":1620,"activeCount":8},[],{"trials":1622,"activeCount":8},[],{"intervention":1608,"totalTrials":20,"cells":1624},{"EARLY_PHASE1":1625,"PHASE1":1627,"PHASE2":1637,"PHASE3":1639,"PHASE4":1641,"NA":1643},{"trials":1626,"activeCount":8},[],{"trials":1628,"activeCount":8},[1629,1633],{"nctId":1603,"briefTitle":1604,"status":123,"phases":1630,"primaryCompletion":804,"completion":804,"start":1511,"enrollment":608,"conditions":1631,"interventions":1632},[35],[13],[1596,1608],{"nctId":1610,"briefTitle":1611,"status":123,"phases":1634,"primaryCompletion":804,"completion":804,"start":1511,"enrollment":608,"conditions":1635,"interventions":1636},[35],[13],[1596,1608],{"trials":1638,"activeCount":8},[],{"trials":1640,"activeCount":8},[],{"trials":1642,"activeCount":8},[],{"trials":1644,"activeCount":8},[],{"intervention":1646,"totalTrials":20,"cells":1647},"Valacyclovir",{"EARLY_PHASE1":1648,"PHASE1":1650,"PHASE2":1665,"PHASE3":1667,"PHASE4":1669,"NA":1671},{"trials":1649,"activeCount":8},[],{"trials":1651,"activeCount":8},[1652,1658],{"nctId":1653,"briefTitle":1654,"status":123,"phases":1655,"primaryCompletion":1511,"completion":1511,"start":1511,"enrollment":632,"conditions":1656,"interventions":1657},"NCT01149460","Valacyclovir 1000 mg Tablet Under Fed Conditions",[35],[13],[1646,1646],{"nctId":1659,"briefTitle":1660,"status":123,"phases":1661,"primaryCompletion":1662,"completion":1662,"start":1662,"enrollment":531,"conditions":1663,"interventions":1664},"NCT01149499","Valacyclovir 1000 mg Tablet Under Fasting Conditions",[35],"2005-01",[13],[1646,1646],{"trials":1666,"activeCount":8},[],{"trials":1668,"activeCount":8},[],{"trials":1670,"activeCount":8},[],{"trials":1672,"activeCount":8},[],{"intervention":1674,"totalTrials":20,"cells":1675},"Amlodipine-benazepril 10 mg-20 mg",{"EARLY_PHASE1":1676,"PHASE1":1678,"PHASE2":1695,"PHASE3":1697,"PHASE4":1699,"NA":1701},{"trials":1677,"activeCount":8},[],{"trials":1679,"activeCount":8},[1680,1687],{"nctId":1681,"briefTitle":1682,"status":123,"phases":1683,"primaryCompletion":883,"completion":883,"start":1166,"enrollment":664,"conditions":1684,"interventions":1685},"NCT00834977","Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fasting Conditions",[35],[13],[1674,1686],"Lotrel® 10 mg-20 mg",{"nctId":1688,"briefTitle":1689,"status":123,"phases":1690,"primaryCompletion":1691,"completion":1691,"start":1691,"enrollment":1692,"conditions":1693,"interventions":1694},"NCT00835367","Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fed Conditions",[35],"2004-03",68,[13],[1674,1686],{"trials":1696,"activeCount":8},[],{"trials":1698,"activeCount":8},[],{"trials":1700,"activeCount":8},[],{"trials":1702,"activeCount":8},[],{"intervention":1686,"totalTrials":20,"cells":1704},{"EARLY_PHASE1":1705,"PHASE1":1707,"PHASE2":1717,"PHASE3":1719,"PHASE4":1721,"NA":1723},{"trials":1706,"activeCount":8},[],{"trials":1708,"activeCount":8},[1709,1713],{"nctId":1681,"briefTitle":1682,"status":123,"phases":1710,"primaryCompletion":883,"completion":883,"start":1166,"enrollment":664,"conditions":1711,"interventions":1712},[35],[13],[1674,1686],{"nctId":1688,"briefTitle":1689,"status":123,"phases":1714,"primaryCompletion":1691,"completion":1691,"start":1691,"enrollment":1692,"conditions":1715,"interventions":1716},[35],[13],[1674,1686],{"trials":1718,"activeCount":8},[],{"trials":1720,"activeCount":8},[],{"trials":1722,"activeCount":8},[],{"trials":1724,"activeCount":8},[],{"intervention":611,"totalTrials":20,"cells":1726},{"EARLY_PHASE1":1727,"PHASE1":1729,"PHASE2":1739,"PHASE3":1741,"PHASE4":1743,"NA":1745},{"trials":1728,"activeCount":8},[],{"trials":1730,"activeCount":8},[1731,1735],{"nctId":603,"briefTitle":604,"status":123,"phases":1732,"primaryCompletion":606,"completion":606,"start":607,"enrollment":608,"conditions":1733,"interventions":1734},[35],[13],[611,596],{"nctId":613,"briefTitle":614,"status":123,"phases":1736,"primaryCompletion":606,"completion":606,"start":607,"enrollment":608,"conditions":1737,"interventions":1738},[35],[13],[611,596],{"trials":1740,"activeCount":8},[],{"trials":1742,"activeCount":8},[],{"trials":1744,"activeCount":8},[],{"trials":1746,"activeCount":8},[],{"intervention":1748,"totalTrials":20,"cells":1749},"Meloxicam 15 mg",{"EARLY_PHASE1":1750,"PHASE1":1752,"PHASE2":1768,"PHASE3":1770,"PHASE4":1772,"NA":1774},{"trials":1751,"activeCount":8},[],{"trials":1753,"activeCount":8},[1754,1762],{"nctId":1755,"briefTitle":1756,"status":123,"phases":1757,"primaryCompletion":1758,"completion":1758,"start":1758,"enrollment":1503,"conditions":1759,"interventions":1760},"NCT00840476","Meloxicam 15 mg Tablets Under Fasting Conditions",[35],"2004-02",[13],[1748,1761],"Mobic® 15 mg",{"nctId":1763,"briefTitle":1764,"status":123,"phases":1765,"primaryCompletion":1758,"completion":1758,"start":1758,"enrollment":1503,"conditions":1766,"interventions":1767},"NCT00840879","Meloxicam 15 mg Tablets Under Non-Fasting Conditions",[35],[13],[1748,1761],{"trials":1769,"activeCount":8},[],{"trials":1771,"activeCount":8},[],{"trials":1773,"activeCount":8},[],{"trials":1775,"activeCount":8},[],{"intervention":1761,"totalTrials":20,"cells":1777},{"EARLY_PHASE1":1778,"PHASE1":1780,"PHASE2":1790,"PHASE3":1792,"PHASE4":1794,"NA":1796},{"trials":1779,"activeCount":8},[],{"trials":1781,"activeCount":8},[1782,1786],{"nctId":1755,"briefTitle":1756,"status":123,"phases":1783,"primaryCompletion":1758,"completion":1758,"start":1758,"enrollment":1503,"conditions":1784,"interventions":1785},[35],[13],[1748,1761],{"nctId":1763,"briefTitle":1764,"status":123,"phases":1787,"primaryCompletion":1758,"completion":1758,"start":1758,"enrollment":1503,"conditions":1788,"interventions":1789},[35],[13],[1748,1761],{"trials":1791,"activeCount":8},[],{"trials":1793,"activeCount":8},[],{"trials":1795,"activeCount":8},[],{"trials":1797,"activeCount":8},[],{"intervention":1799,"totalTrials":20,"cells":1800},"Moexipril HCl\u002Fhydrochlorothiazide 15\u002F25 mg",{"EARLY_PHASE1":1801,"PHASE1":1803,"PHASE2":1820,"PHASE3":1822,"PHASE4":1824,"NA":1826},{"trials":1802,"activeCount":8},[],{"trials":1804,"activeCount":8},[1805,1814],{"nctId":1806,"briefTitle":1807,"status":123,"phases":1808,"primaryCompletion":1809,"completion":1809,"start":1810,"enrollment":531,"conditions":1811,"interventions":1812},"NCT00834067","Moexipril HCl\u002FHydrochlorothiazide 15\u002F25 mg Tablets Under Non-Fasting Conditions",[35],"2003-11","2003-10",[13],[1799,1813],"UNIRETIC® 15\u002F25 mg",{"nctId":1815,"briefTitle":1816,"status":123,"phases":1817,"primaryCompletion":1809,"completion":1809,"start":1810,"enrollment":531,"conditions":1818,"interventions":1819},"NCT00835042","Moexipril HCL\u002FHydrochlorothiazide 15\u002F25 mg Tablets Under Fasting Conditions",[35],[13],[1799,1813],{"trials":1821,"activeCount":8},[],{"trials":1823,"activeCount":8},[],{"trials":1825,"activeCount":8},[],{"trials":1827,"activeCount":8},[],{"intervention":1813,"totalTrials":20,"cells":1829},{"EARLY_PHASE1":1830,"PHASE1":1832,"PHASE2":1842,"PHASE3":1844,"PHASE4":1846,"NA":1848},{"trials":1831,"activeCount":8},[],{"trials":1833,"activeCount":8},[1834,1838],{"nctId":1806,"briefTitle":1807,"status":123,"phases":1835,"primaryCompletion":1809,"completion":1809,"start":1810,"enrollment":531,"conditions":1836,"interventions":1837},[35],[13],[1799,1813],{"nctId":1815,"briefTitle":1816,"status":123,"phases":1839,"primaryCompletion":1809,"completion":1809,"start":1810,"enrollment":531,"conditions":1840,"interventions":1841},[35],[13],[1799,1813],{"trials":1843,"activeCount":8},[],{"trials":1845,"activeCount":8},[],{"trials":1847,"activeCount":8},[],{"trials":1849,"activeCount":8},[],{"intervention":1851,"totalTrials":20,"cells":1852},"Glucophage® XR 750 mg",{"EARLY_PHASE1":1853,"PHASE1":1855,"PHASE2":1870,"PHASE3":1872,"PHASE4":1874,"NA":1876},{"trials":1854,"activeCount":8},[],{"trials":1856,"activeCount":8},[1857,1864],{"nctId":1858,"briefTitle":1859,"status":123,"phases":1860,"primaryCompletion":865,"completion":865,"start":865,"enrollment":1325,"conditions":1861,"interventions":1862},"NCT00834743","Metformin ER 750 mg Tablets, Fasting",[35],[13],[1851,1863],"Metformin ER 750 mg",{"nctId":1865,"briefTitle":1866,"status":123,"phases":1867,"primaryCompletion":865,"completion":865,"start":865,"enrollment":1325,"conditions":1868,"interventions":1869},"NCT00834613","Metformin ER 750 mg Tablets, Fed",[35],[13],[1851,1863],{"trials":1871,"activeCount":8},[],{"trials":1873,"activeCount":8},[],{"trials":1875,"activeCount":8},[],{"trials":1877,"activeCount":8},[],{"intervention":1863,"totalTrials":20,"cells":1879},{"EARLY_PHASE1":1880,"PHASE1":1882,"PHASE2":1892,"PHASE3":1894,"PHASE4":1896,"NA":1898},{"trials":1881,"activeCount":8},[],{"trials":1883,"activeCount":8},[1884,1888],{"nctId":1858,"briefTitle":1859,"status":123,"phases":1885,"primaryCompletion":865,"completion":865,"start":865,"enrollment":1325,"conditions":1886,"interventions":1887},[35],[13],[1851,1863],{"nctId":1865,"briefTitle":1866,"status":123,"phases":1889,"primaryCompletion":865,"completion":865,"start":865,"enrollment":1325,"conditions":1890,"interventions":1891},[35],[13],[1851,1863],{"trials":1893,"activeCount":8},[],{"trials":1895,"activeCount":8},[],{"trials":1897,"activeCount":8},[],{"trials":1899,"activeCount":8},[],{"intervention":1901,"totalTrials":20,"cells":1902},"Oxcarbazepine",{"EARLY_PHASE1":1903,"PHASE1":1905,"PHASE2":1924,"PHASE3":1926,"PHASE4":1928,"NA":1930},{"trials":1904,"activeCount":8},[],{"trials":1906,"activeCount":8},[1907,1916],{"nctId":1908,"briefTitle":1909,"status":123,"phases":1910,"primaryCompletion":1911,"completion":1911,"start":1911,"enrollment":1912,"conditions":1913,"interventions":1914},"NCT00849797","Oxcarbazepine 600 mg Tablets Under Non-Fasting Conditions",[35],"2005-07",120,[13],[1901,1915],"Trileptal®",{"nctId":1917,"briefTitle":1918,"status":123,"phases":1919,"primaryCompletion":1920,"completion":1920,"start":1921,"enrollment":531,"conditions":1922,"interventions":1923},"NCT00850174","Oxcarbazepine 600 mg Tablets Under Fasting Conditions",[35],"2005-05","2005-04",[13],[1901,1915],{"trials":1925,"activeCount":8},[],{"trials":1927,"activeCount":8},[],{"trials":1929,"activeCount":8},[],{"trials":1931,"activeCount":8},[],{"intervention":1915,"totalTrials":20,"cells":1933},{"EARLY_PHASE1":1934,"PHASE1":1936,"PHASE2":1946,"PHASE3":1948,"PHASE4":1950,"NA":1952},{"trials":1935,"activeCount":8},[],{"trials":1937,"activeCount":8},[1938,1942],{"nctId":1908,"briefTitle":1909,"status":123,"phases":1939,"primaryCompletion":1911,"completion":1911,"start":1911,"enrollment":1912,"conditions":1940,"interventions":1941},[35],[13],[1901,1915],{"nctId":1917,"briefTitle":1918,"status":123,"phases":1943,"primaryCompletion":1920,"completion":1920,"start":1921,"enrollment":531,"conditions":1944,"interventions":1945},[35],[13],[1901,1915],{"trials":1947,"activeCount":8},[],{"trials":1949,"activeCount":8},[],{"trials":1951,"activeCount":8},[],{"trials":1953,"activeCount":8},[],{"intervention":1955,"totalTrials":20,"cells":1956},"Pantoprazole Sodium 40 mg delayed-release",{"EARLY_PHASE1":1957,"PHASE1":1959,"PHASE2":1976,"PHASE3":1978,"PHASE4":1980,"NA":1982},{"trials":1958,"activeCount":8},[],{"trials":1960,"activeCount":8},[1961,1969],{"nctId":1962,"briefTitle":1963,"status":123,"phases":1964,"primaryCompletion":1965,"completion":1965,"start":1965,"enrollment":866,"conditions":1966,"interventions":1967},"NCT00835393","Pantoprazole Sodium 40 mg DR Tablets Under Non-Fasting Conditions",[35],"2003-12",[13],[1955,1968],"PROTONIX® 40 mg delayed-release tablets.",{"nctId":1970,"briefTitle":1971,"status":123,"phases":1972,"primaryCompletion":1965,"completion":1965,"start":1965,"enrollment":1973,"conditions":1974,"interventions":1975},"NCT00835588","Pantoprazole Sodium 40 mg DR Tablets Under Fasting Conditions",[35],100,[13],[1955,1968],{"trials":1977,"activeCount":8},[],{"trials":1979,"activeCount":8},[],{"trials":1981,"activeCount":8},[],{"trials":1983,"activeCount":8},[],{"intervention":1968,"totalTrials":20,"cells":1985},{"EARLY_PHASE1":1986,"PHASE1":1988,"PHASE2":1998,"PHASE3":2000,"PHASE4":2002,"NA":2004},{"trials":1987,"activeCount":8},[],{"trials":1989,"activeCount":8},[1990,1994],{"nctId":1962,"briefTitle":1963,"status":123,"phases":1991,"primaryCompletion":1965,"completion":1965,"start":1965,"enrollment":866,"conditions":1992,"interventions":1993},[35],[13],[1955,1968],{"nctId":1970,"briefTitle":1971,"status":123,"phases":1995,"primaryCompletion":1965,"completion":1965,"start":1965,"enrollment":1973,"conditions":1996,"interventions":1997},[35],[13],[1955,1968],{"trials":1999,"activeCount":8},[],{"trials":2001,"activeCount":8},[],{"trials":2003,"activeCount":8},[],{"trials":2005,"activeCount":8},[],{"intervention":2007,"totalTrials":20,"cells":2008},"Clarithromycin ER 500 mg",{"EARLY_PHASE1":2009,"PHASE1":2011,"PHASE2":2028,"PHASE3":2030,"PHASE4":2032,"NA":2034},{"trials":2010,"activeCount":8},[],{"trials":2012,"activeCount":8},[2013,2021],{"nctId":2014,"briefTitle":2015,"status":123,"phases":2016,"primaryCompletion":2017,"completion":2017,"start":2017,"enrollment":731,"conditions":2018,"interventions":2019},"NCT00840216","Clarithromycin 500 mg Extended Release Tablets Under Non-Fasting Conditions.",[35],"2002-08",[13],[2007,2020],"BIAXIN® XL 500 mg",{"nctId":2022,"briefTitle":2023,"status":123,"phases":2024,"primaryCompletion":932,"completion":932,"start":933,"enrollment":2025,"conditions":2026,"interventions":2027},"NCT00840411","Clarithromycin 500 mg Extended Release Tablets Under Fasting Conditions",[35],66,[13],[2007,2020],{"trials":2029,"activeCount":8},[],{"trials":2031,"activeCount":8},[],{"trials":2033,"activeCount":8},[],{"trials":2035,"activeCount":8},[],{"intervention":2020,"totalTrials":20,"cells":2037},{"EARLY_PHASE1":2038,"PHASE1":2040,"PHASE2":2050,"PHASE3":2052,"PHASE4":2054,"NA":2056},{"trials":2039,"activeCount":8},[],{"trials":2041,"activeCount":8},[2042,2046],{"nctId":2014,"briefTitle":2015,"status":123,"phases":2043,"primaryCompletion":2017,"completion":2017,"start":2017,"enrollment":731,"conditions":2044,"interventions":2045},[35],[13],[2007,2020],{"nctId":2022,"briefTitle":2023,"status":123,"phases":2047,"primaryCompletion":932,"completion":932,"start":933,"enrollment":2025,"conditions":2048,"interventions":2049},[35],[13],[2007,2020],{"trials":2051,"activeCount":8},[],{"trials":2053,"activeCount":8},[],{"trials":2055,"activeCount":8},[],{"trials":2057,"activeCount":8},[],{"intervention":2059,"totalTrials":20,"cells":2060},"Drospirenone\u002FEthinyl Estradiol",{"EARLY_PHASE1":2061,"PHASE1":2063,"PHASE2":2080,"PHASE3":2082,"PHASE4":2084,"NA":2086},{"trials":2062,"activeCount":8},[],{"trials":2064,"activeCount":8},[2065,2073],{"nctId":2066,"briefTitle":2067,"status":123,"phases":2068,"primaryCompletion":539,"completion":539,"start":540,"enrollment":2069,"conditions":2070,"interventions":2071},"NCT01182207","Drospirenone\u002FEthinyl Estradiol (3 mg\u002F0.02 mg) Tablets Under Non-Fasting Conditions",[35],33,[13],[2059,2072],"YAZ®",{"nctId":2074,"briefTitle":2075,"status":123,"phases":2076,"primaryCompletion":539,"completion":539,"start":2077,"enrollment":1325,"conditions":2078,"interventions":2079},"NCT01182194","Drospirenone\u002FEthinyl Estradiol (3 mg\u002F0.02 mg) Tablets Under Fasting Conditions.",[35],"2006-06",[13],[2059,2072],{"trials":2081,"activeCount":8},[],{"trials":2083,"activeCount":8},[],{"trials":2085,"activeCount":8},[],{"trials":2087,"activeCount":8},[],{"intervention":2072,"totalTrials":20,"cells":2089},{"EARLY_PHASE1":2090,"PHASE1":2092,"PHASE2":2102,"PHASE3":2104,"PHASE4":2106,"NA":2108},{"trials":2091,"activeCount":8},[],{"trials":2093,"activeCount":8},[2094,2098],{"nctId":2066,"briefTitle":2067,"status":123,"phases":2095,"primaryCompletion":539,"completion":539,"start":540,"enrollment":2069,"conditions":2096,"interventions":2097},[35],[13],[2059,2072],{"nctId":2074,"briefTitle":2075,"status":123,"phases":2099,"primaryCompletion":539,"completion":539,"start":2077,"enrollment":1325,"conditions":2100,"interventions":2101},[35],[13],[2059,2072],{"trials":2103,"activeCount":8},[],{"trials":2105,"activeCount":8},[],{"trials":2107,"activeCount":8},[],{"trials":2109,"activeCount":8},[],{"intervention":2111,"totalTrials":20,"cells":2112},"Amlodipine Besylate",{"EARLY_PHASE1":2113,"PHASE1":2115,"PHASE2":2132,"PHASE3":2134,"PHASE4":2136,"NA":2138},{"trials":2114,"activeCount":8},[],{"trials":2116,"activeCount":8},[2117,2126],{"nctId":2118,"briefTitle":2119,"status":123,"phases":2120,"primaryCompletion":2121,"completion":2121,"start":2122,"enrollment":1503,"conditions":2123,"interventions":2124},"NCT00841542","Amlodipine 10 mg Tablets Under Fasting Conditions",[35],"2003-05","2003-04",[13],[2111,2125],"Norvasc®",{"nctId":2127,"briefTitle":2128,"status":123,"phases":2129,"primaryCompletion":2121,"completion":2121,"start":2122,"enrollment":1503,"conditions":2130,"interventions":2131},"NCT00841815","Amlodipine 10 mg Tablets Under Fed Conditions",[35],[13],[2111,2125],{"trials":2133,"activeCount":8},[],{"trials":2135,"activeCount":8},[],{"trials":2137,"activeCount":8},[],{"trials":2139,"activeCount":8},[],{"intervention":2125,"totalTrials":20,"cells":2141},{"EARLY_PHASE1":2142,"PHASE1":2144,"PHASE2":2154,"PHASE3":2156,"PHASE4":2158,"NA":2160},{"trials":2143,"activeCount":8},[],{"trials":2145,"activeCount":8},[2146,2150],{"nctId":2118,"briefTitle":2119,"status":123,"phases":2147,"primaryCompletion":2121,"completion":2121,"start":2122,"enrollment":1503,"conditions":2148,"interventions":2149},[35],[13],[2111,2125],{"nctId":2127,"briefTitle":2128,"status":123,"phases":2151,"primaryCompletion":2121,"completion":2121,"start":2122,"enrollment":1503,"conditions":2152,"interventions":2153},[35],[13],[2111,2125],{"trials":2155,"activeCount":8},[],{"trials":2157,"activeCount":8},[],{"trials":2159,"activeCount":8},[],{"trials":2161,"activeCount":8},[],{"intervention":2163,"totalTrials":20,"cells":2164},"Zaleplon 10 mg",{"EARLY_PHASE1":2165,"PHASE1":2167,"PHASE2":2184,"PHASE3":2186,"PHASE4":2188,"NA":2190},{"trials":2166,"activeCount":8},[],{"trials":2168,"activeCount":8},[2169,2177],{"nctId":2170,"briefTitle":2171,"status":123,"phases":2172,"primaryCompletion":1691,"completion":1691,"start":1758,"enrollment":2173,"conditions":2174,"interventions":2175},"NCT00829868","Zaleplon 10 mg Capsules Under Non-Fasting Conditions",[35],42,[13],[2163,2176],"SONATA® 10 mg",{"nctId":2178,"briefTitle":2179,"status":123,"phases":2180,"primaryCompletion":1758,"completion":1758,"start":1758,"enrollment":541,"conditions":2181,"interventions":2182},"NCT00829998","Zaleplon 10mg Capsules Under Fasting Conditions",[35],[13],[2163,2183],"Sonata® 10 mg",{"trials":2185,"activeCount":8},[],{"trials":2187,"activeCount":8},[],{"trials":2189,"activeCount":8},[],{"trials":2191,"activeCount":8},[],{"intervention":2176,"totalTrials":20,"cells":2193},{"EARLY_PHASE1":2194,"PHASE1":2196,"PHASE2":2206,"PHASE3":2208,"PHASE4":2210,"NA":2212},{"trials":2195,"activeCount":8},[],{"trials":2197,"activeCount":8},[2198,2202],{"nctId":2170,"briefTitle":2171,"status":123,"phases":2199,"primaryCompletion":1691,"completion":1691,"start":1758,"enrollment":2173,"conditions":2200,"interventions":2201},[35],[13],[2163,2176],{"nctId":2178,"briefTitle":2179,"status":123,"phases":2203,"primaryCompletion":1758,"completion":1758,"start":1758,"enrollment":541,"conditions":2204,"interventions":2205},[35],[13],[2163,2183],{"trials":2207,"activeCount":8},[],{"trials":2209,"activeCount":8},[],{"trials":2211,"activeCount":8},[],{"trials":2213,"activeCount":8},[],{"intervention":2215,"totalTrials":20,"cells":2216},"600 mg Amoxicillin\u002F42.9 mg Clavulanate Postassium \u002F5 mL",{"EARLY_PHASE1":2217,"PHASE1":2219,"PHASE2":2235,"PHASE3":2237,"PHASE4":2239,"NA":2241},{"trials":2218,"activeCount":8},[],{"trials":2220,"activeCount":8},[2221,2228],{"nctId":2222,"briefTitle":2223,"status":123,"phases":2224,"primaryCompletion":2017,"completion":2017,"start":2017,"enrollment":664,"conditions":2225,"interventions":2226},"NCT00840099","600 mg Amoxicillin\u002F42.9 mg Clavulanate Postassium \u002F5 mL Suspension Under Fasting Conditions",[35],[13],[2215,2227],"Augmentin ES-600™ 600 mg\u002F42.9 mg\u002F5 mL Suspension",{"nctId":2229,"briefTitle":2230,"status":123,"phases":2231,"primaryCompletion":2017,"completion":2017,"start":2017,"enrollment":664,"conditions":2232,"interventions":2233},"NCT00840840","600 mg Amoxicillin\u002F42.9 mg Clavulanate Postassium \u002F5 mL Suspension Under Fed Conditions",[35],[13],[2215,2234],"Augmentin ES-600™",{"trials":2236,"activeCount":8},[],{"trials":2238,"activeCount":8},[],{"trials":2240,"activeCount":8},[],{"trials":2242,"activeCount":8},[],{"intervention":2244,"totalTrials":20,"cells":2245},"Topiramate Capsules, 25 mg",{"EARLY_PHASE1":2246,"PHASE1":2248,"PHASE2":2263,"PHASE3":2265,"PHASE4":2267,"NA":2269},{"trials":2247,"activeCount":8},[],{"trials":2249,"activeCount":8},[2250,2257],{"nctId":2251,"briefTitle":2252,"status":123,"phases":2253,"primaryCompletion":1220,"completion":1220,"start":1221,"enrollment":934,"conditions":2254,"interventions":2255},"NCT00904943","Topiramate 25 mg Capsules Under Fed Conditions",[35],[13],[2244,2256],"Topamax® Capsules, 25 mg",{"nctId":2258,"briefTitle":2259,"status":123,"phases":2260,"primaryCompletion":1221,"completion":1221,"start":1221,"enrollment":655,"conditions":2261,"interventions":2262},"NCT00905164","Topiramate 25 mg Capsules Under Fasting Conditions",[35],[13],[2244,2256],{"trials":2264,"activeCount":8},[],{"trials":2266,"activeCount":8},[],{"trials":2268,"activeCount":8},[],{"trials":2270,"activeCount":8},[],{"intervention":2256,"totalTrials":20,"cells":2272},{"EARLY_PHASE1":2273,"PHASE1":2275,"PHASE2":2285,"PHASE3":2287,"PHASE4":2289,"NA":2291},{"trials":2274,"activeCount":8},[],{"trials":2276,"activeCount":8},[2277,2281],{"nctId":2251,"briefTitle":2252,"status":123,"phases":2278,"primaryCompletion":1220,"completion":1220,"start":1221,"enrollment":934,"conditions":2279,"interventions":2280},[35],[13],[2244,2256],{"nctId":2258,"briefTitle":2259,"status":123,"phases":2282,"primaryCompletion":1221,"completion":1221,"start":1221,"enrollment":655,"conditions":2283,"interventions":2284},[35],[13],[2244,2256],{"trials":2286,"activeCount":8},[],{"trials":2288,"activeCount":8},[],{"trials":2290,"activeCount":8},[],{"trials":2292,"activeCount":8},[],{"intervention":2294,"totalTrials":20,"cells":2295},"amoxicillin-clavulanic acid",{"EARLY_PHASE1":2296,"PHASE1":2298,"PHASE2":2314,"PHASE3":2316,"PHASE4":2318,"NA":2320},{"trials":2297,"activeCount":8},[],{"trials":2299,"activeCount":8},[2300,2308],{"nctId":2301,"briefTitle":2302,"status":123,"phases":2303,"primaryCompletion":654,"completion":654,"start":654,"enrollment":2304,"conditions":2305,"interventions":2306},"NCT00836901","Amoxicillin-Clavulanic Acid 400 Mg-57 mg Chewable Tablets Under Non-Fasting Conditions",[35],52,[13],[2294,2307],"Augmentin®",{"nctId":2309,"briefTitle":2310,"status":123,"phases":2311,"primaryCompletion":654,"completion":654,"start":654,"enrollment":2304,"conditions":2312,"interventions":2313},"NCT00835705","Amoxicillin-Clavulanic Acid 400 Mg-57 mg Chewable Tablets Under Fasting Conditions",[35],[13],[2294,2307],{"trials":2315,"activeCount":8},[],{"trials":2317,"activeCount":8},[],{"trials":2319,"activeCount":8},[],{"trials":2321,"activeCount":8},[],{"intervention":2307,"totalTrials":20,"cells":2323},{"EARLY_PHASE1":2324,"PHASE1":2326,"PHASE2":2336,"PHASE3":2338,"PHASE4":2340,"NA":2342},{"trials":2325,"activeCount":8},[],{"trials":2327,"activeCount":8},[2328,2332],{"nctId":2301,"briefTitle":2302,"status":123,"phases":2329,"primaryCompletion":654,"completion":654,"start":654,"enrollment":2304,"conditions":2330,"interventions":2331},[35],[13],[2294,2307],{"nctId":2309,"briefTitle":2310,"status":123,"phases":2333,"primaryCompletion":654,"completion":654,"start":654,"enrollment":2304,"conditions":2334,"interventions":2335},[35],[13],[2294,2307],{"trials":2337,"activeCount":8},[],{"trials":2339,"activeCount":8},[],{"trials":2341,"activeCount":8},[],{"trials":2343,"activeCount":8},[],{"intervention":2345,"totalTrials":20,"cells":2346},"Losartan",{"EARLY_PHASE1":2347,"PHASE1":2349,"PHASE2":2365,"PHASE3":2367,"PHASE4":2369,"NA":2371},{"trials":2348,"activeCount":8},[],{"trials":2350,"activeCount":8},[2351,2359],{"nctId":2352,"briefTitle":2353,"status":123,"phases":2354,"primaryCompletion":1809,"completion":1809,"start":1810,"enrollment":2355,"conditions":2356,"interventions":2357},"NCT01124162","Losartan 100 mg Tablets in Healthy Subjects Under Fasting Conditions",[35],80,[13],[2345,2358],"Cozaar®",{"nctId":2360,"briefTitle":2361,"status":123,"phases":2362,"primaryCompletion":1809,"completion":1809,"start":1810,"enrollment":2355,"conditions":2363,"interventions":2364},"NCT01124175","Losartan 100 mg Tablet in Healthy Subjects Under Non-Fasting Conditions",[35],[13],[2345,2358],{"trials":2366,"activeCount":8},[],{"trials":2368,"activeCount":8},[],{"trials":2370,"activeCount":8},[],{"trials":2372,"activeCount":8},[],{"intervention":2358,"totalTrials":20,"cells":2374},{"EARLY_PHASE1":2375,"PHASE1":2377,"PHASE2":2387,"PHASE3":2389,"PHASE4":2391,"NA":2393},{"trials":2376,"activeCount":8},[],{"trials":2378,"activeCount":8},[2379,2383],{"nctId":2352,"briefTitle":2353,"status":123,"phases":2380,"primaryCompletion":1809,"completion":1809,"start":1810,"enrollment":2355,"conditions":2381,"interventions":2382},[35],[13],[2345,2358],{"nctId":2360,"briefTitle":2361,"status":123,"phases":2384,"primaryCompletion":1809,"completion":1809,"start":1810,"enrollment":2355,"conditions":2385,"interventions":2386},[35],[13],[2345,2358],{"trials":2388,"activeCount":8},[],{"trials":2390,"activeCount":8},[],{"trials":2392,"activeCount":8},[],{"trials":2394,"activeCount":8},[],{"intervention":2396,"totalTrials":20,"cells":2397},"Finasteride 5 mg",{"EARLY_PHASE1":2398,"PHASE1":2400,"PHASE2":2417,"PHASE3":2419,"PHASE4":2421,"NA":2423},{"trials":2399,"activeCount":8},[],{"trials":2401,"activeCount":8},[2402,2410],{"nctId":2403,"briefTitle":2404,"status":123,"phases":2405,"primaryCompletion":1220,"completion":1220,"start":1221,"enrollment":2406,"conditions":2407,"interventions":2408},"NCT00835796","Finasteride 5 mg Tablets, Non-fasting",[35],20,[13],[2396,2409],"PROSCAR® 5mg",{"nctId":2411,"briefTitle":2412,"status":123,"phases":2413,"primaryCompletion":1221,"completion":1221,"start":1221,"enrollment":1325,"conditions":2414,"interventions":2415},"NCT00835666","Finasteride 5 mg Tablets Under Fasting Conditions",[35],[13],[2396,2416],"PROSCAR®",{"trials":2418,"activeCount":8},[],{"trials":2420,"activeCount":8},[],{"trials":2422,"activeCount":8},[],{"trials":2424,"activeCount":8},[],{"intervention":2426,"totalTrials":20,"cells":2427},"Mirtazapine 15 mg (Orally Disintegrating)",{"EARLY_PHASE1":2428,"PHASE1":2430,"PHASE2":2446,"PHASE3":2448,"PHASE4":2450,"NA":2452},{"trials":2429,"activeCount":8},[],{"trials":2431,"activeCount":8},[2432,2440],{"nctId":2433,"briefTitle":2434,"status":123,"phases":2435,"primaryCompletion":865,"completion":865,"start":2436,"enrollment":1325,"conditions":2437,"interventions":2438},"NCT00835575","15 mg Mirtazapine Orally Disintegrating Tablets, Fasting",[35],"2003-07",[13],[2426,2439],"REMERON SolTab® 15 mg Orally Disintegrating",{"nctId":2441,"briefTitle":2442,"status":123,"phases":2443,"primaryCompletion":865,"completion":865,"start":2436,"enrollment":1325,"conditions":2444,"interventions":2445},"NCT00834197","15 mg Mirtazapine Orally Disintegrating Tablets, Non-Fasting",[35],[13],[2426,2439],{"trials":2447,"activeCount":8},[],{"trials":2449,"activeCount":8},[],{"trials":2451,"activeCount":8},[],{"trials":2453,"activeCount":8},[],{"intervention":2439,"totalTrials":20,"cells":2455},{"EARLY_PHASE1":2456,"PHASE1":2458,"PHASE2":2468,"PHASE3":2470,"PHASE4":2472,"NA":2474},{"trials":2457,"activeCount":8},[],{"trials":2459,"activeCount":8},[2460,2464],{"nctId":2433,"briefTitle":2434,"status":123,"phases":2461,"primaryCompletion":865,"completion":865,"start":2436,"enrollment":1325,"conditions":2462,"interventions":2463},[35],[13],[2426,2439],{"nctId":2441,"briefTitle":2442,"status":123,"phases":2465,"primaryCompletion":865,"completion":865,"start":2436,"enrollment":1325,"conditions":2466,"interventions":2467},[35],[13],[2426,2439],{"trials":2469,"activeCount":8},[],{"trials":2471,"activeCount":8},[],{"trials":2473,"activeCount":8},[],{"trials":2475,"activeCount":8},[],{"intervention":2477,"totalTrials":20,"cells":2478},"Ribavirin 200 mg",{"EARLY_PHASE1":2479,"PHASE1":2481,"PHASE2":2498,"PHASE3":2500,"PHASE4":2502,"NA":2504},{"trials":2480,"activeCount":8},[],{"trials":2482,"activeCount":8},[2483,2490],{"nctId":2484,"briefTitle":2485,"status":123,"phases":2486,"primaryCompletion":1810,"completion":1810,"start":654,"enrollment":1503,"conditions":2487,"interventions":2488},"NCT00835146","Ribavirin 200 mg Tablets Under Fasting Conditions",[35],[13],[2477,2489],"COPEGUS™",{"nctId":2491,"briefTitle":2492,"status":123,"phases":2493,"primaryCompletion":1810,"completion":1810,"start":654,"enrollment":2494,"conditions":2495,"interventions":2496},"NCT00835536","Ribavirin 200 mg Tablets Under Non-Fasting Conditions",[35],27,[13],[2477,2497],"COPEGUS™ 200 mg",{"trials":2499,"activeCount":8},[],{"trials":2501,"activeCount":8},[],{"trials":2503,"activeCount":8},[],{"trials":2505,"activeCount":8},[],{"intervention":2507,"totalTrials":20,"cells":2508},"Trandolapril 4 mg",{"EARLY_PHASE1":2509,"PHASE1":2511,"PHASE2":2527,"PHASE3":2529,"PHASE4":2531,"NA":2533},{"trials":2510,"activeCount":8},[],{"trials":2512,"activeCount":8},[2513,2521],{"nctId":2514,"briefTitle":2515,"status":123,"phases":2516,"primaryCompletion":2517,"completion":2517,"start":804,"enrollment":866,"conditions":2518,"interventions":2519},"NCT00840073","Trandolapril 4 mg Tablet Under Non-Fasting Conditions",[35],"2004-11",[13],[2507,2520],"Mavik® 4 mg",{"nctId":2522,"briefTitle":2523,"status":123,"phases":2524,"primaryCompletion":2517,"completion":2517,"start":804,"enrollment":541,"conditions":2525,"interventions":2526},"NCT00840632","Trandolapril 4 mg Tablet Under Fasting Conditions",[35],[13],[2507,2520],{"trials":2528,"activeCount":8},[],{"trials":2530,"activeCount":8},[],{"trials":2532,"activeCount":8},[],{"trials":2534,"activeCount":8},[],{"intervention":2520,"totalTrials":20,"cells":2536},{"EARLY_PHASE1":2537,"PHASE1":2539,"PHASE2":2549,"PHASE3":2551,"PHASE4":2553,"NA":2555},{"trials":2538,"activeCount":8},[],{"trials":2540,"activeCount":8},[2541,2545],{"nctId":2514,"briefTitle":2515,"status":123,"phases":2542,"primaryCompletion":2517,"completion":2517,"start":804,"enrollment":866,"conditions":2543,"interventions":2544},[35],[13],[2507,2520],{"nctId":2522,"briefTitle":2523,"status":123,"phases":2546,"primaryCompletion":2517,"completion":2517,"start":804,"enrollment":541,"conditions":2547,"interventions":2548},[35],[13],[2507,2520],{"trials":2550,"activeCount":8},[],{"trials":2552,"activeCount":8},[],{"trials":2554,"activeCount":8},[],{"trials":2556,"activeCount":8},[],{"intervention":2558,"totalTrials":20,"cells":2559},"Bicalutamide",{"EARLY_PHASE1":2560,"PHASE1":2562,"PHASE2":2577,"PHASE3":2579,"PHASE4":2581,"NA":2583},{"trials":2561,"activeCount":8},[],{"trials":2563,"activeCount":8},[2564,2571],{"nctId":2565,"briefTitle":2566,"status":123,"phases":2567,"primaryCompletion":654,"completion":654,"start":654,"enrollment":531,"conditions":2568,"interventions":2569},"NCT00972855","Study of Bicalutamide 1 x 50 mg Tablet in Healthy Subjects Under Fed Conditions",[35],[13],[2558,2570],"Casodex®",{"nctId":2572,"briefTitle":2573,"status":123,"phases":2574,"primaryCompletion":654,"completion":654,"start":654,"enrollment":531,"conditions":2575,"interventions":2576},"NCT00973050","Study of Bicalutamide 1 x 50 mg Tablet in Healthy Subjects Under Fasting Conditions",[35],[13],[2558,2570],{"trials":2578,"activeCount":8},[],{"trials":2580,"activeCount":8},[],{"trials":2582,"activeCount":8},[],{"trials":2584,"activeCount":8},[],{"intervention":2570,"totalTrials":20,"cells":2586},{"EARLY_PHASE1":2587,"PHASE1":2589,"PHASE2":2599,"PHASE3":2601,"PHASE4":2603,"NA":2605},{"trials":2588,"activeCount":8},[],{"trials":2590,"activeCount":8},[2591,2595],{"nctId":2565,"briefTitle":2566,"status":123,"phases":2592,"primaryCompletion":654,"completion":654,"start":654,"enrollment":531,"conditions":2593,"interventions":2594},[35],[13],[2558,2570],{"nctId":2572,"briefTitle":2573,"status":123,"phases":2596,"primaryCompletion":654,"completion":654,"start":654,"enrollment":531,"conditions":2597,"interventions":2598},[35],[13],[2558,2570],{"trials":2600,"activeCount":8},[],{"trials":2602,"activeCount":8},[],{"trials":2604,"activeCount":8},[],{"trials":2606,"activeCount":8},[],{"intervention":2608,"totalTrials":20,"cells":2609},"Estradiol\u002FNorethindrone acetate",{"EARLY_PHASE1":2610,"PHASE1":2612,"PHASE2":2629,"PHASE3":2631,"PHASE4":2633,"NA":2635},{"trials":2611,"activeCount":8},[],{"trials":2613,"activeCount":8},[2614,2623],{"nctId":2615,"briefTitle":2616,"status":123,"phases":2617,"primaryCompletion":2618,"completion":2618,"start":2619,"enrollment":632,"conditions":2620,"interventions":2621},"NCT01157182","Estradiol\u002FNorethindrone Acetate Tablets, 1\u002F0.5 mg Under Fasting Conditions",[35],"2007-04","2007-02",[13],[2608,2622],"Activella®",{"nctId":2624,"briefTitle":2625,"status":123,"phases":2626,"primaryCompletion":2619,"completion":2619,"start":739,"enrollment":541,"conditions":2627,"interventions":2628},"NCT01181726","Estradiol\u002FNorethindrone Acetate Tablets, 1\u002F0.5 mg Under Fed Conditions",[35],[13],[2608,2622],{"trials":2630,"activeCount":8},[],{"trials":2632,"activeCount":8},[],{"trials":2634,"activeCount":8},[],{"trials":2636,"activeCount":8},[],{"intervention":2622,"totalTrials":20,"cells":2638},{"EARLY_PHASE1":2639,"PHASE1":2641,"PHASE2":2651,"PHASE3":2653,"PHASE4":2655,"NA":2657},{"trials":2640,"activeCount":8},[],{"trials":2642,"activeCount":8},[2643,2647],{"nctId":2615,"briefTitle":2616,"status":123,"phases":2644,"primaryCompletion":2618,"completion":2618,"start":2619,"enrollment":632,"conditions":2645,"interventions":2646},[35],[13],[2608,2622],{"nctId":2624,"briefTitle":2625,"status":123,"phases":2648,"primaryCompletion":2619,"completion":2619,"start":739,"enrollment":541,"conditions":2649,"interventions":2650},[35],[13],[2608,2622],{"trials":2652,"activeCount":8},[],{"trials":2654,"activeCount":8},[],{"trials":2656,"activeCount":8},[],{"trials":2658,"activeCount":8},[],{"intervention":2660,"totalTrials":20,"cells":2661},"Cefdinir for oral suspension 250 mg\u002F5mL",{"EARLY_PHASE1":2662,"PHASE1":2664,"PHASE2":2681,"PHASE3":2683,"PHASE4":2685,"NA":2687},{"trials":2663,"activeCount":8},[],{"trials":2665,"activeCount":8},[2666,2675],{"nctId":2667,"briefTitle":2668,"status":123,"phases":2669,"primaryCompletion":2670,"completion":2670,"start":2671,"enrollment":1325,"conditions":2672,"interventions":2673},"NCT00834574","Cefdinir for Oral Suspension 250 mg\u002F5mL, Fasting",[35],"2005-03","2005-02",[13],[2660,2674],"OMNICEF® for oral suspension 250 mg\u002F5mL",{"nctId":2676,"briefTitle":2677,"status":123,"phases":2678,"primaryCompletion":2670,"completion":2670,"start":2670,"enrollment":1325,"conditions":2679,"interventions":2680},"NCT00835549","Cefdinir for Oral Suspension 250 mg\u002F5mL, Non-fasting",[35],[13],[2660,2674],{"trials":2682,"activeCount":8},[],{"trials":2684,"activeCount":8},[],{"trials":2686,"activeCount":8},[],{"trials":2688,"activeCount":8},[],{"intervention":2674,"totalTrials":20,"cells":2690},{"EARLY_PHASE1":2691,"PHASE1":2693,"PHASE2":2703,"PHASE3":2705,"PHASE4":2707,"NA":2709},{"trials":2692,"activeCount":8},[],{"trials":2694,"activeCount":8},[2695,2699],{"nctId":2667,"briefTitle":2668,"status":123,"phases":2696,"primaryCompletion":2670,"completion":2670,"start":2671,"enrollment":1325,"conditions":2697,"interventions":2698},[35],[13],[2660,2674],{"nctId":2676,"briefTitle":2677,"status":123,"phases":2700,"primaryCompletion":2670,"completion":2670,"start":2670,"enrollment":1325,"conditions":2701,"interventions":2702},[35],[13],[2660,2674],{"trials":2704,"activeCount":8},[],{"trials":2706,"activeCount":8},[],{"trials":2708,"activeCount":8},[],{"trials":2710,"activeCount":8},[],{"intervention":2712,"totalTrials":20,"cells":2713},"Losartan potassium\u002FHydrochlorothiazide",{"EARLY_PHASE1":2714,"PHASE1":2716,"PHASE2":2731,"PHASE3":2733,"PHASE4":2735,"NA":2737},{"trials":2715,"activeCount":8},[],{"trials":2717,"activeCount":8},[2718,2725],{"nctId":2719,"briefTitle":2720,"status":123,"phases":2721,"primaryCompletion":1758,"completion":1758,"start":874,"enrollment":2406,"conditions":2722,"interventions":2723},"NCT01149486","Losartan Potassium\u002FHydrochlorothiazide 100\u002F25 mg Tablets in Healthy Subjects Under Fasting Conditions",[35],[13],[2712,2724],"Hyzaar®",{"nctId":2726,"briefTitle":2727,"status":123,"phases":2728,"primaryCompletion":1166,"completion":1166,"start":1691,"enrollment":2355,"conditions":2729,"interventions":2730},"NCT01149473","Losartan Potassium\u002FHydrochlorothiazide 100\u002F25 mg Tablets in Healthy Subjects Under Non-Fasting Conditions",[35],[13],[2712,2712],{"trials":2732,"activeCount":8},[],{"trials":2734,"activeCount":8},[],{"trials":2736,"activeCount":8},[],{"trials":2738,"activeCount":8},[],{"intervention":2740,"totalTrials":20,"cells":2741},"Terbinafine HCl 250mg",{"EARLY_PHASE1":2742,"PHASE1":2744,"PHASE2":2759,"PHASE3":2761,"PHASE4":2763,"NA":2765},{"trials":2743,"activeCount":8},[],{"trials":2745,"activeCount":8},[2746,2753],{"nctId":2747,"briefTitle":2748,"status":123,"phases":2749,"primaryCompletion":454,"completion":454,"start":454,"enrollment":1503,"conditions":2750,"interventions":2751},"NCT00833586","Terbinafine HCl 250 mg Tablet Under Fasting Conditions",[35],[13],[2740,2752],"Lamisil® 250 mg",{"nctId":2754,"briefTitle":2755,"status":123,"phases":2756,"primaryCompletion":454,"completion":454,"start":454,"enrollment":731,"conditions":2757,"interventions":2758},"NCT00833664","Terbinafine HCl 250 mg Tablet Formulations Under Non-Fasting Conditions",[35],[13],[2740,2752],{"trials":2760,"activeCount":8},[],{"trials":2762,"activeCount":8},[],{"trials":2764,"activeCount":8},[],{"trials":2766,"activeCount":8},[],{"intervention":2752,"totalTrials":20,"cells":2768},{"EARLY_PHASE1":2769,"PHASE1":2771,"PHASE2":2781,"PHASE3":2783,"PHASE4":2785,"NA":2787},{"trials":2770,"activeCount":8},[],{"trials":2772,"activeCount":8},[2773,2777],{"nctId":2747,"briefTitle":2748,"status":123,"phases":2774,"primaryCompletion":454,"completion":454,"start":454,"enrollment":1503,"conditions":2775,"interventions":2776},[35],[13],[2740,2752],{"nctId":2754,"briefTitle":2755,"status":123,"phases":2778,"primaryCompletion":454,"completion":454,"start":454,"enrollment":731,"conditions":2779,"interventions":2780},[35],[13],[2740,2752],{"trials":2782,"activeCount":8},[],{"trials":2784,"activeCount":8},[],{"trials":2786,"activeCount":8},[],{"trials":2788,"activeCount":8},[],{"intervention":2790,"totalTrials":20,"cells":2791},"Zithromax®",{"EARLY_PHASE1":2792,"PHASE1":2794,"PHASE2":2810,"PHASE3":2812,"PHASE4":2814,"NA":2816},{"trials":2793,"activeCount":8},[],{"trials":2795,"activeCount":8},[2796,2803],{"nctId":2797,"briefTitle":2798,"status":123,"phases":2799,"primaryCompletion":2800,"completion":2800,"start":2800,"enrollment":2355,"conditions":2801,"interventions":2802},"NCT00830206","A Relative Bioavailability Study of 200mg\u002F5 mL Azithromycin Oral Suspension Under Fasting Conditions",[35],"2006-01",[13],[2790],{"nctId":2804,"briefTitle":2805,"status":123,"phases":2806,"primaryCompletion":729,"completion":729,"start":730,"enrollment":2355,"conditions":2807,"interventions":2808},"NCT00830336","A Relative Bioavailability Study of 200mg\u002F5 mL Azithromycin Oral Suspension Under Non-Fasting Conditions",[35],[13],[2809,2790],"Azithromycin",{"trials":2811,"activeCount":8},[],{"trials":2813,"activeCount":8},[],{"trials":2815,"activeCount":8},[],{"trials":2817,"activeCount":8},[],{"intervention":2819,"totalTrials":20,"cells":2820},"Pravachol®",{"EARLY_PHASE1":2821,"PHASE1":2823,"PHASE2":2842,"PHASE3":2844,"PHASE4":2846,"NA":2848},{"trials":2822,"activeCount":8},[],{"trials":2824,"activeCount":8},[2825,2834],{"nctId":2826,"briefTitle":2827,"status":123,"phases":2828,"primaryCompletion":2829,"completion":2829,"start":2829,"enrollment":2830,"conditions":2831,"interventions":2832},"NCT00834379","Bioavailability Study of Pravastatin Sodium 40 mg Tablets Under Fasting Conditions",[35],"2000-09",58,[13],[2833,2819],"pravastatin sodium",{"nctId":2835,"briefTitle":2836,"status":123,"phases":2837,"primaryCompletion":2829,"completion":2829,"start":2838,"enrollment":655,"conditions":2839,"interventions":2840},"NCT00834847","Pravastatin Sodium 40 mg Tablets Food Challenge Study",[35],"2000-08",[13],[2841,2819],"pravastatin",{"trials":2843,"activeCount":8},[],{"trials":2845,"activeCount":8},[],{"trials":2847,"activeCount":8},[],{"trials":2849,"activeCount":8},[],{"intervention":2851,"totalTrials":20,"cells":2852},"Fexofenadine 180 mg",{"EARLY_PHASE1":2853,"PHASE1":2855,"PHASE2":2871,"PHASE3":2873,"PHASE4":2875,"NA":2877},{"trials":2854,"activeCount":8},[],{"trials":2856,"activeCount":8},[2857,2864],{"nctId":2858,"briefTitle":2859,"status":123,"phases":2860,"primaryCompletion":454,"completion":454,"start":454,"enrollment":655,"conditions":2861,"interventions":2862},"NCT00835640","Fexofenadine Hydrochloride 180 mg Tablets Under Non-Fasting Conditions",[35],[13],[2851,2863],"ALLEGRA® 180 mg",{"nctId":2865,"briefTitle":2866,"status":123,"phases":2867,"primaryCompletion":2868,"completion":2868,"start":2868,"enrollment":531,"conditions":2869,"interventions":2870},"NCT00835276","Fexofenadine Hydrochloride 180 mg Tablets Under Fasting Conditions",[35],"2002-03",[13],[2851,2863],{"trials":2872,"activeCount":8},[],{"trials":2874,"activeCount":8},[],{"trials":2876,"activeCount":8},[],{"trials":2878,"activeCount":8},[],{"intervention":2863,"totalTrials":20,"cells":2880},{"EARLY_PHASE1":2881,"PHASE1":2883,"PHASE2":2893,"PHASE3":2895,"PHASE4":2897,"NA":2899},{"trials":2882,"activeCount":8},[],{"trials":2884,"activeCount":8},[2885,2889],{"nctId":2858,"briefTitle":2859,"status":123,"phases":2886,"primaryCompletion":454,"completion":454,"start":454,"enrollment":655,"conditions":2887,"interventions":2888},[35],[13],[2851,2863],{"nctId":2865,"briefTitle":2866,"status":123,"phases":2890,"primaryCompletion":2868,"completion":2868,"start":2868,"enrollment":531,"conditions":2891,"interventions":2892},[35],[13],[2851,2863],{"trials":2894,"activeCount":8},[],{"trials":2896,"activeCount":8},[],{"trials":2898,"activeCount":8},[],{"trials":2900,"activeCount":8},[],{"intervention":2902,"totalTrials":20,"cells":2903},"Glyburide\u002FMetformin 5 mg\u002F500 mg",{"EARLY_PHASE1":2904,"PHASE1":2906,"PHASE2":2921,"PHASE3":2923,"PHASE4":2925,"NA":2927},{"trials":2905,"activeCount":8},[],{"trials":2907,"activeCount":8},[2908,2915],{"nctId":2909,"briefTitle":2910,"status":123,"phases":2911,"primaryCompletion":942,"completion":942,"start":942,"enrollment":531,"conditions":2912,"interventions":2913},"NCT00835991","Glyburide\u002FMetformin 5 mg\u002F500 mg Film-Coated Tablets, Fed",[35],[13],[2902,2914],"Glucovance® 5 mg\u002F500 mg",{"nctId":2916,"briefTitle":2917,"status":123,"phases":2918,"primaryCompletion":2122,"completion":2122,"start":2122,"enrollment":531,"conditions":2919,"interventions":2920},"NCT00836472","Glyburide\u002FMetformin 5 mg\u002F500 mg Film-Coated Tablets, Fasting",[35],[13],[2902,2914],{"trials":2922,"activeCount":8},[],{"trials":2924,"activeCount":8},[],{"trials":2926,"activeCount":8},[],{"trials":2928,"activeCount":8},[],{"intervention":2914,"totalTrials":20,"cells":2930},{"EARLY_PHASE1":2931,"PHASE1":2933,"PHASE2":2943,"PHASE3":2945,"PHASE4":2947,"NA":2949},{"trials":2932,"activeCount":8},[],{"trials":2934,"activeCount":8},[2935,2939],{"nctId":2909,"briefTitle":2910,"status":123,"phases":2936,"primaryCompletion":942,"completion":942,"start":942,"enrollment":531,"conditions":2937,"interventions":2938},[35],[13],[2902,2914],{"nctId":2916,"briefTitle":2917,"status":123,"phases":2940,"primaryCompletion":2122,"completion":2122,"start":2122,"enrollment":531,"conditions":2941,"interventions":2942},[35],[13],[2902,2914],{"trials":2944,"activeCount":8},[],{"trials":2946,"activeCount":8},[],{"trials":2948,"activeCount":8},[],{"trials":2950,"activeCount":8},[],{"intervention":2952,"totalTrials":20,"cells":2953},"Anastrozole",{"EARLY_PHASE1":2954,"PHASE1":2956,"PHASE2":2972,"PHASE3":2974,"PHASE4":2976,"NA":2978},{"trials":2955,"activeCount":8},[],{"trials":2957,"activeCount":8},[2958,2965],{"nctId":2959,"briefTitle":2960,"status":123,"phases":2961,"primaryCompletion":730,"completion":730,"start":2962,"enrollment":731,"conditions":2963,"interventions":2964},"NCT01183390","Anastrozole 1 mg Tablets Under Fed Conditions",[35],"2005-09",[13],[2952,2952],{"nctId":2966,"briefTitle":2967,"status":123,"phases":2968,"primaryCompletion":2962,"completion":2962,"start":2969,"enrollment":731,"conditions":2970,"interventions":2971},"NCT01182181","Anastrozole 1 mg Tablets Under Fasting Conditions",[35],"2005-08",[13],[2952,2952],{"trials":2973,"activeCount":8},[],{"trials":2975,"activeCount":8},[],{"trials":2977,"activeCount":8},[],{"trials":2979,"activeCount":8},[],{"intervention":2981,"totalTrials":20,"cells":2982},"Granisetron hydrochloride 1 mg",{"EARLY_PHASE1":2983,"PHASE1":2985,"PHASE2":3000,"PHASE3":3002,"PHASE4":3004,"NA":3006},{"trials":2984,"activeCount":8},[],{"trials":2986,"activeCount":8},[2987,2994],{"nctId":2988,"briefTitle":2989,"status":123,"phases":2990,"primaryCompletion":2962,"completion":2962,"start":2962,"enrollment":541,"conditions":2991,"interventions":2992},"NCT00834717","Granisetron 1 mg Tablets Under Fasting Conditions",[35],[13],[2981,2993],"Kytril® 1 mg",{"nctId":2995,"briefTitle":2996,"status":123,"phases":2997,"primaryCompletion":1911,"completion":1911,"start":1911,"enrollment":2355,"conditions":2998,"interventions":2999},"NCT00834522","Granisetron 1 mg Tablets, Non-fasting",[35],[13],[2981,2993],{"trials":3001,"activeCount":8},[],{"trials":3003,"activeCount":8},[],{"trials":3005,"activeCount":8},[],{"trials":3007,"activeCount":8},[],{"intervention":2993,"totalTrials":20,"cells":3009},{"EARLY_PHASE1":3010,"PHASE1":3012,"PHASE2":3022,"PHASE3":3024,"PHASE4":3026,"NA":3028},{"trials":3011,"activeCount":8},[],{"trials":3013,"activeCount":8},[3014,3018],{"nctId":2988,"briefTitle":2989,"status":123,"phases":3015,"primaryCompletion":2962,"completion":2962,"start":2962,"enrollment":541,"conditions":3016,"interventions":3017},[35],[13],[2981,2993],{"nctId":2995,"briefTitle":2996,"status":123,"phases":3019,"primaryCompletion":1911,"completion":1911,"start":1911,"enrollment":2355,"conditions":3020,"interventions":3021},[35],[13],[2981,2993],{"trials":3023,"activeCount":8},[],{"trials":3025,"activeCount":8},[],{"trials":3027,"activeCount":8},[],{"trials":3029,"activeCount":8},[],{"intervention":3031,"totalTrials":20,"cells":3032},"clarithromycin",{"EARLY_PHASE1":3033,"PHASE1":3035,"PHASE2":3052,"PHASE3":3054,"PHASE4":3056,"NA":3058},{"trials":3034,"activeCount":8},[],{"trials":3036,"activeCount":8},[3037,3044],{"nctId":3038,"briefTitle":3039,"status":123,"phases":3040,"primaryCompletion":1220,"completion":1220,"start":1220,"enrollment":655,"conditions":3041,"interventions":3042},"NCT00836706","Clarithromycin 500 mg Tablets Under Non-Fasting Conditions",[35],[13],[3031,3043],"BIAXIN®",{"nctId":3045,"briefTitle":3046,"status":123,"phases":3047,"primaryCompletion":933,"completion":933,"start":933,"enrollment":531,"conditions":3048,"interventions":3049},"NCT00835692","Clarithromycin 500 mg Tablets Under Fasting Conditions",[35],[13],[3050,3051],"Clarithromycin","Biaxin®",{"trials":3053,"activeCount":8},[],{"trials":3055,"activeCount":8},[],{"trials":3057,"activeCount":8},[],{"trials":3059,"activeCount":8},[],{"intervention":3043,"totalTrials":20,"cells":3061},{"EARLY_PHASE1":3062,"PHASE1":3064,"PHASE2":3074,"PHASE3":3076,"PHASE4":3078,"NA":3080},{"trials":3063,"activeCount":8},[],{"trials":3065,"activeCount":8},[3066,3070],{"nctId":3038,"briefTitle":3039,"status":123,"phases":3067,"primaryCompletion":1220,"completion":1220,"start":1220,"enrollment":655,"conditions":3068,"interventions":3069},[35],[13],[3031,3043],{"nctId":3045,"briefTitle":3046,"status":123,"phases":3071,"primaryCompletion":933,"completion":933,"start":933,"enrollment":531,"conditions":3072,"interventions":3073},[35],[13],[3050,3051],{"trials":3075,"activeCount":8},[],{"trials":3077,"activeCount":8},[],{"trials":3079,"activeCount":8},[],{"trials":3081,"activeCount":8},[],{"intervention":3083,"totalTrials":20,"cells":3084},"Alprazolam Extended-Release 3 mg",{"EARLY_PHASE1":3085,"PHASE1":3087,"PHASE2":3102,"PHASE3":3104,"PHASE4":3106,"NA":3108},{"trials":3086,"activeCount":8},[],{"trials":3088,"activeCount":8},[3089,3096],{"nctId":3090,"briefTitle":3091,"status":123,"phases":3092,"primaryCompletion":3093,"completion":3093,"start":3093,"enrollment":632,"conditions":3094,"interventions":3095},"NCT00830024","Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Non-fasting Conditions",[35],"2005-06",[13],[3083,3083],{"nctId":3097,"briefTitle":3098,"status":123,"phases":3099,"primaryCompletion":3093,"completion":3093,"start":3093,"enrollment":1325,"conditions":3100,"interventions":3101},"NCT00829426","Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Fasting Conditions",[35],[13],[3083,3083],{"trials":3103,"activeCount":8},[],{"trials":3105,"activeCount":8},[],{"trials":3107,"activeCount":8},[],{"trials":3109,"activeCount":8},[],{"intervention":3111,"totalTrials":20,"cells":3112},"Pravastatin",{"EARLY_PHASE1":3113,"PHASE1":3115,"PHASE2":3128,"PHASE3":3130,"PHASE4":3132,"NA":3134},{"trials":3114,"activeCount":8},[],{"trials":3116,"activeCount":8},[3117,3124],{"nctId":3118,"briefTitle":3119,"status":123,"phases":3120,"primaryCompletion":2670,"completion":2670,"start":2670,"enrollment":3121,"conditions":3122,"interventions":3123},"NCT00829309","Pravastatin 80 mg Tablets Dosed in Healthy Subjects Under Non-Fasting Conditions",[35],16,[13],[3111,3111],{"nctId":2835,"briefTitle":2836,"status":123,"phases":3125,"primaryCompletion":2829,"completion":2829,"start":2838,"enrollment":655,"conditions":3126,"interventions":3127},[35],[13],[2841,2819],{"trials":3129,"activeCount":8},[],{"trials":3131,"activeCount":8},[],{"trials":3133,"activeCount":8},[],{"trials":3135,"activeCount":8},[],{"intervention":3137,"totalTrials":20,"cells":3138},"Zolpidem 10 mg",{"EARLY_PHASE1":3139,"PHASE1":3141,"PHASE2":3157,"PHASE3":3159,"PHASE4":3161,"NA":3163},{"trials":3140,"activeCount":8},[],{"trials":3142,"activeCount":8},[3143,3151],{"nctId":3144,"briefTitle":3145,"status":123,"phases":3146,"primaryCompletion":3147,"completion":3147,"start":3147,"enrollment":455,"conditions":3148,"interventions":3149},"NCT00833521","Zolpidem Tartrate 10 mg Tablets Under Fasting Conditions",[35],"2002-02",[13],[3137,3150],"AMBIEN® 10 mg",{"nctId":3152,"briefTitle":3153,"status":123,"phases":3154,"primaryCompletion":2868,"completion":2868,"start":2868,"enrollment":655,"conditions":3155,"interventions":3156},"NCT00833937","Zolpidem Tartrate 10 mg Tablets Under Non-Fasting Conditions",[35],[13],[3137,3150],{"trials":3158,"activeCount":8},[],{"trials":3160,"activeCount":8},[],{"trials":3162,"activeCount":8},[],{"trials":3164,"activeCount":8},[],{"intervention":3150,"totalTrials":20,"cells":3166},{"EARLY_PHASE1":3167,"PHASE1":3169,"PHASE2":3179,"PHASE3":3181,"PHASE4":3183,"NA":3185},{"trials":3168,"activeCount":8},[],{"trials":3170,"activeCount":8},[3171,3175],{"nctId":3144,"briefTitle":3145,"status":123,"phases":3172,"primaryCompletion":3147,"completion":3147,"start":3147,"enrollment":455,"conditions":3173,"interventions":3174},[35],[13],[3137,3150],{"nctId":3152,"briefTitle":3153,"status":123,"phases":3176,"primaryCompletion":2868,"completion":2868,"start":2868,"enrollment":655,"conditions":3177,"interventions":3178},[35],[13],[3137,3150],{"trials":3180,"activeCount":8},[],{"trials":3182,"activeCount":8},[],{"trials":3184,"activeCount":8},[],{"trials":3186,"activeCount":8},[],{"intervention":3188,"totalTrials":20,"cells":3189},"Ondansetron",{"EARLY_PHASE1":3190,"PHASE1":3192,"PHASE2":3207,"PHASE3":3209,"PHASE4":3211,"NA":3213},{"trials":3191,"activeCount":8},[],{"trials":3193,"activeCount":8},[3194,3201],{"nctId":3195,"briefTitle":3196,"status":123,"phases":3197,"primaryCompletion":942,"completion":942,"start":942,"enrollment":655,"conditions":3198,"interventions":3199},"NCT00934921","Ondansetron HCl Orally Disintegrating Tablets Under Non-Fasting Conditions",[35],[13],[3188,3200],"Zofran®",{"nctId":3202,"briefTitle":3203,"status":123,"phases":3204,"primaryCompletion":1555,"completion":1555,"start":1555,"enrollment":655,"conditions":3205,"interventions":3206},"NCT00934180","Ondansetron HCl Orally Disintegrating Tablets Under Fasting Conditions",[35],[13],[3188,3200],{"trials":3208,"activeCount":8},[],{"trials":3210,"activeCount":8},[],{"trials":3212,"activeCount":8},[],{"trials":3214,"activeCount":8},[],{"intervention":3200,"totalTrials":20,"cells":3216},{"EARLY_PHASE1":3217,"PHASE1":3219,"PHASE2":3229,"PHASE3":3231,"PHASE4":3233,"NA":3235},{"trials":3218,"activeCount":8},[],{"trials":3220,"activeCount":8},[3221,3225],{"nctId":3195,"briefTitle":3196,"status":123,"phases":3222,"primaryCompletion":942,"completion":942,"start":942,"enrollment":655,"conditions":3223,"interventions":3224},[35],[13],[3188,3200],{"nctId":3202,"briefTitle":3203,"status":123,"phases":3226,"primaryCompletion":1555,"completion":1555,"start":1555,"enrollment":655,"conditions":3227,"interventions":3228},[35],[13],[3188,3200],{"trials":3230,"activeCount":8},[],{"trials":3232,"activeCount":8},[],{"trials":3234,"activeCount":8},[],{"trials":3236,"activeCount":8},[],{"intervention":3238,"totalTrials":20,"cells":3239},"Tamsulosin",{"EARLY_PHASE1":3240,"PHASE1":3242,"PHASE2":3257,"PHASE3":3259,"PHASE4":3261,"NA":3263},{"trials":3241,"activeCount":8},[],{"trials":3243,"activeCount":8},[3244,3251],{"nctId":3245,"briefTitle":3246,"status":123,"phases":3247,"primaryCompletion":3248,"completion":3248,"start":3248,"enrollment":1325,"conditions":3249,"interventions":3250},"NCT01149746","Tamsulosin Hydrochloride 0.4 mg Capsules Under Fasting Conditions",[35],"2004-12",[13],[3238,3238],{"nctId":3252,"briefTitle":3253,"status":123,"phases":3254,"primaryCompletion":2517,"completion":2517,"start":2517,"enrollment":1325,"conditions":3255,"interventions":3256},"NCT01149733","Tamsulosin Hydrochloride 0.4 mg Capsules Under Fed Conditions",[35],[13],[3238,3238],{"trials":3258,"activeCount":8},[],{"trials":3260,"activeCount":8},[],{"trials":3262,"activeCount":8},[],{"trials":3264,"activeCount":8},[],{"intervention":3266,"totalTrials":20,"cells":3267},"Famciclovir 500 mg",{"EARLY_PHASE1":3268,"PHASE1":3270,"PHASE2":3285,"PHASE3":3287,"PHASE4":3289,"NA":3291},{"trials":3269,"activeCount":8},[],{"trials":3271,"activeCount":8},[3272,3279],{"nctId":3273,"briefTitle":3274,"status":123,"phases":3275,"primaryCompletion":1511,"completion":1511,"start":805,"enrollment":632,"conditions":3276,"interventions":3277},"NCT00834431","Famciclovir 500 mg Tablets Under Fasting Conditions",[35],[13],[3266,3278],"Famvir® 500 mg",{"nctId":3280,"briefTitle":3281,"status":123,"phases":3282,"primaryCompletion":1511,"completion":1511,"start":805,"enrollment":632,"conditions":3283,"interventions":3284},"NCT00834444","Famciclovir 500 mg Tablets Under Non-Fasting Conditions",[35],[13],[3266,3278],{"trials":3286,"activeCount":8},[],{"trials":3288,"activeCount":8},[],{"trials":3290,"activeCount":8},[],{"trials":3292,"activeCount":8},[],{"intervention":3278,"totalTrials":20,"cells":3294},{"EARLY_PHASE1":3295,"PHASE1":3297,"PHASE2":3307,"PHASE3":3309,"PHASE4":3311,"NA":3313},{"trials":3296,"activeCount":8},[],{"trials":3298,"activeCount":8},[3299,3303],{"nctId":3273,"briefTitle":3274,"status":123,"phases":3300,"primaryCompletion":1511,"completion":1511,"start":805,"enrollment":632,"conditions":3301,"interventions":3302},[35],[13],[3266,3278],{"nctId":3280,"briefTitle":3281,"status":123,"phases":3304,"primaryCompletion":1511,"completion":1511,"start":805,"enrollment":632,"conditions":3305,"interventions":3306},[35],[13],[3266,3278],{"trials":3308,"activeCount":8},[],{"trials":3310,"activeCount":8},[],{"trials":3312,"activeCount":8},[],{"trials":3314,"activeCount":8},[],{"intervention":3316,"totalTrials":20,"cells":3317},"Cefdinir Capsules 300 mg",{"EARLY_PHASE1":3318,"PHASE1":3320,"PHASE2":3336,"PHASE3":3338,"PHASE4":3340,"NA":3342},{"trials":3319,"activeCount":8},[],{"trials":3321,"activeCount":8},[3322,3329],{"nctId":3323,"briefTitle":3324,"status":123,"phases":3325,"primaryCompletion":1911,"completion":1911,"start":1911,"enrollment":1325,"conditions":3326,"interventions":3327},"NCT00835484","Cefdinir Capsules 300 mg, Fasting",[35],[13],[3316,3328],"OMNICEF® 300 mg",{"nctId":3330,"briefTitle":3331,"status":123,"phases":3332,"primaryCompletion":2969,"completion":2969,"start":1911,"enrollment":1325,"conditions":3333,"interventions":3334},"NCT00834535","Cefdinir Capsules 300 mg, Non-fasting",[35],[13],[3316,3335],"OMNICEF® Capsule 300 mg",{"trials":3337,"activeCount":8},[],{"trials":3339,"activeCount":8},[],{"trials":3341,"activeCount":8},[],{"trials":3343,"activeCount":8},[],{"intervention":3345,"totalTrials":20,"cells":3346},"Lamotrigine 25 mg Chewable",{"EARLY_PHASE1":3347,"PHASE1":3349,"PHASE2":3364,"PHASE3":3366,"PHASE4":3368,"NA":3370},{"trials":3348,"activeCount":8},[],{"trials":3350,"activeCount":8},[3351,3358],{"nctId":3352,"briefTitle":3353,"status":123,"phases":3354,"primaryCompletion":2868,"completion":2868,"start":3147,"enrollment":1325,"conditions":3355,"interventions":3356},"NCT00838279","Lamotrigine 25 mg Chewable Tablets, Fasting",[35],[13],[3345,3357],"Lamictal® 25 mg Chewable",{"nctId":3359,"briefTitle":3360,"status":123,"phases":3361,"primaryCompletion":2868,"completion":2868,"start":3147,"enrollment":1325,"conditions":3362,"interventions":3363},"NCT00838136","Lamotrigine 25 mg Chewable Tablets, Non-Fasting",[35],[13],[3345,3357],{"trials":3365,"activeCount":8},[],{"trials":3367,"activeCount":8},[],{"trials":3369,"activeCount":8},[],{"trials":3371,"activeCount":8},[],{"intervention":3357,"totalTrials":20,"cells":3373},{"EARLY_PHASE1":3374,"PHASE1":3376,"PHASE2":3386,"PHASE3":3388,"PHASE4":3390,"NA":3392},{"trials":3375,"activeCount":8},[],{"trials":3377,"activeCount":8},[3378,3382],{"nctId":3352,"briefTitle":3353,"status":123,"phases":3379,"primaryCompletion":2868,"completion":2868,"start":3147,"enrollment":1325,"conditions":3380,"interventions":3381},[35],[13],[3345,3357],{"nctId":3359,"briefTitle":3360,"status":123,"phases":3383,"primaryCompletion":2868,"completion":2868,"start":3147,"enrollment":1325,"conditions":3384,"interventions":3385},[35],[13],[3345,3357],{"trials":3387,"activeCount":8},[],{"trials":3389,"activeCount":8},[],{"trials":3391,"activeCount":8},[],{"trials":3393,"activeCount":8},[],{"intervention":3395,"totalTrials":20,"cells":3396},"Lamotrigine",{"EARLY_PHASE1":3397,"PHASE1":3399,"PHASE2":3414,"PHASE3":3416,"PHASE4":3418,"NA":3420},{"trials":3398,"activeCount":8},[],{"trials":3400,"activeCount":8},[3401,3408],{"nctId":3402,"briefTitle":3403,"status":123,"phases":3404,"primaryCompletion":3147,"completion":3147,"start":454,"enrollment":1325,"conditions":3405,"interventions":3406},"NCT00834561","Bioequivalence Study of 200 mg Lamotrigine Tablet Under Fasting Conditions",[35],[13],[3395,3407],"Lamictal®",{"nctId":3409,"briefTitle":3410,"status":123,"phases":3411,"primaryCompletion":3147,"completion":3147,"start":454,"enrollment":1325,"conditions":3412,"interventions":3413},"NCT00835263","Bioequivalence Study of 200 mg Lamotrigine Tablet Under Non-Fasting Conditions",[35],[13],[3395,3407],{"trials":3415,"activeCount":8},[],{"trials":3417,"activeCount":8},[],{"trials":3419,"activeCount":8},[],{"trials":3421,"activeCount":8},[],{"intervention":3407,"totalTrials":20,"cells":3423},{"EARLY_PHASE1":3424,"PHASE1":3426,"PHASE2":3436,"PHASE3":3438,"PHASE4":3440,"NA":3442},{"trials":3425,"activeCount":8},[],{"trials":3427,"activeCount":8},[3428,3432],{"nctId":3402,"briefTitle":3403,"status":123,"phases":3429,"primaryCompletion":3147,"completion":3147,"start":454,"enrollment":1325,"conditions":3430,"interventions":3431},[35],[13],[3395,3407],{"nctId":3409,"briefTitle":3410,"status":123,"phases":3433,"primaryCompletion":3147,"completion":3147,"start":454,"enrollment":1325,"conditions":3434,"interventions":3435},[35],[13],[3395,3407],{"trials":3437,"activeCount":8},[],{"trials":3439,"activeCount":8},[],{"trials":3441,"activeCount":8},[],{"trials":3443,"activeCount":8},[],{"intervention":3445,"totalTrials":20,"cells":3446},"Ropinirole HCl 0.25 mg",{"EARLY_PHASE1":3447,"PHASE1":3449,"PHASE2":3466,"PHASE3":3468,"PHASE4":3470,"NA":3472},{"trials":3448,"activeCount":8},[],{"trials":3450,"activeCount":8},[3451,3459],{"nctId":3452,"briefTitle":3453,"status":123,"phases":3454,"primaryCompletion":804,"completion":804,"start":804,"enrollment":3455,"conditions":3456,"interventions":3457},"NCT00829504","Ropinirole 0.25 mg Tablets Under Fasting Conditions",[35],44,[13],[3445,3458],"Requip® 0.25 mg",{"nctId":3460,"briefTitle":3461,"status":123,"phases":3462,"primaryCompletion":2517,"completion":2517,"start":2517,"enrollment":3463,"conditions":3464,"interventions":3465},"NCT00830219","The Relative Bioavailability Study of Two Ropinirole 0.25 mg Tablets Under Fed Conditions",[35],46,[13],[3445,3458],{"trials":3467,"activeCount":8},[],{"trials":3469,"activeCount":8},[],{"trials":3471,"activeCount":8},[],{"trials":3473,"activeCount":8},[],{"intervention":3458,"totalTrials":20,"cells":3475},{"EARLY_PHASE1":3476,"PHASE1":3478,"PHASE2":3488,"PHASE3":3490,"PHASE4":3492,"NA":3494},{"trials":3477,"activeCount":8},[],{"trials":3479,"activeCount":8},[3480,3484],{"nctId":3452,"briefTitle":3453,"status":123,"phases":3481,"primaryCompletion":804,"completion":804,"start":804,"enrollment":3455,"conditions":3482,"interventions":3483},[35],[13],[3445,3458],{"nctId":3460,"briefTitle":3461,"status":123,"phases":3485,"primaryCompletion":2517,"completion":2517,"start":2517,"enrollment":3463,"conditions":3486,"interventions":3487},[35],[13],[3445,3458],{"trials":3489,"activeCount":8},[],{"trials":3491,"activeCount":8},[],{"trials":3493,"activeCount":8},[],{"trials":3495,"activeCount":8},[],{"intervention":3497,"totalTrials":20,"cells":3498},"Pramipexole Dihydrochloride",{"EARLY_PHASE1":3499,"PHASE1":3501,"PHASE2":3515,"PHASE3":3517,"PHASE4":3519,"NA":3521},{"trials":3500,"activeCount":8},[],{"trials":3502,"activeCount":8},[3503,3509],{"nctId":3504,"briefTitle":3505,"status":123,"phases":3506,"primaryCompletion":2670,"completion":2670,"start":2671,"enrollment":655,"conditions":3507,"interventions":3508},"NCT01074450","Pramipexole Dihydrochloride 0.25 mg Tablets Under Fasting Conditions",[35],[13],[3497,3497],{"nctId":3510,"briefTitle":3511,"status":123,"phases":3512,"primaryCompletion":2670,"completion":2670,"start":2671,"enrollment":655,"conditions":3513,"interventions":3514},"NCT01074463","Pramipexole Dihydrochloride 0.25 mg Tablets Under Non-Fasting Conditions",[35],[13],[3497,3497],{"trials":3516,"activeCount":8},[],{"trials":3518,"activeCount":8},[],{"trials":3520,"activeCount":8},[],{"trials":3522,"activeCount":8},[],{"intervention":3524,"totalTrials":20,"cells":3525},"Clindamycin 300 mg",{"EARLY_PHASE1":3526,"PHASE1":3528,"PHASE2":3543,"PHASE3":3545,"PHASE4":3547,"NA":3549},{"trials":3527,"activeCount":8},[],{"trials":3529,"activeCount":8},[3530,3537],{"nctId":3531,"briefTitle":3532,"status":123,"phases":3533,"primaryCompletion":1809,"completion":1809,"start":1809,"enrollment":655,"conditions":3534,"interventions":3535},"NCT00836056","Clindamycin 300 mg Capsules in Healthy Subjects Under Fasting Conditions",[35],[13],[3524,3536],"Cleocin HCl 300 mg",{"nctId":3538,"briefTitle":3539,"status":123,"phases":3540,"primaryCompletion":1809,"completion":1809,"start":1809,"enrollment":655,"conditions":3541,"interventions":3542},"NCT00836004","Clindamycin 300 mg Capsules in Healthy Subjects Under Fed Conditions",[35],[13],[3524,3536],{"trials":3544,"activeCount":8},[],{"trials":3546,"activeCount":8},[],{"trials":3548,"activeCount":8},[],{"trials":3550,"activeCount":8},[],{"intervention":3536,"totalTrials":20,"cells":3552},{"EARLY_PHASE1":3553,"PHASE1":3555,"PHASE2":3565,"PHASE3":3567,"PHASE4":3569,"NA":3571},{"trials":3554,"activeCount":8},[],{"trials":3556,"activeCount":8},[3557,3561],{"nctId":3531,"briefTitle":3532,"status":123,"phases":3558,"primaryCompletion":1809,"completion":1809,"start":1809,"enrollment":655,"conditions":3559,"interventions":3560},[35],[13],[3524,3536],{"nctId":3538,"briefTitle":3539,"status":123,"phases":3562,"primaryCompletion":1809,"completion":1809,"start":1809,"enrollment":655,"conditions":3563,"interventions":3564},[35],[13],[3524,3536],{"trials":3566,"activeCount":8},[],{"trials":3568,"activeCount":8},[],{"trials":3570,"activeCount":8},[],{"trials":3572,"activeCount":8},[],{"intervention":626,"totalTrials":20,"cells":3574},{"EARLY_PHASE1":3575,"PHASE1":3577,"PHASE2":3587,"PHASE3":3589,"PHASE4":3591,"NA":3593},{"trials":3576,"activeCount":8},[],{"trials":3578,"activeCount":8},[3579,3583],{"nctId":619,"briefTitle":620,"status":123,"phases":3580,"primaryCompletion":622,"completion":622,"start":623,"enrollment":608,"conditions":3581,"interventions":3582},[35],[13],[626,596],{"nctId":628,"briefTitle":629,"status":123,"phases":3584,"primaryCompletion":631,"completion":631,"start":623,"enrollment":632,"conditions":3585,"interventions":3586},[35],[13],[626,596],{"trials":3588,"activeCount":8},[],{"trials":3590,"activeCount":8},[],{"trials":3592,"activeCount":8},[],{"trials":3594,"activeCount":8},[],{"intervention":3596,"totalTrials":20,"cells":3597},"Paroxetine HCl",{"EARLY_PHASE1":3598,"PHASE1":3600,"PHASE2":3615,"PHASE3":3617,"PHASE4":3619,"NA":3621},{"trials":3599,"activeCount":8},[],{"trials":3601,"activeCount":8},[3602,3609],{"nctId":3603,"briefTitle":3604,"status":123,"phases":3605,"primaryCompletion":932,"completion":932,"start":932,"enrollment":866,"conditions":3606,"interventions":3607},"NCT00841698","Paroxetine Hydrochloride 40 mg Tablets Under Fasting Conditions",[35],[13],[3596,3608],"Paxil®",{"nctId":3610,"briefTitle":3611,"status":123,"phases":3612,"primaryCompletion":2017,"completion":2017,"start":2017,"enrollment":655,"conditions":3613,"interventions":3614},"NCT00841659","Paroxetine Hydrochloride 40 mg Tablets Under Fed Conditions",[35],[13],[3596,3608],{"trials":3616,"activeCount":8},[],{"trials":3618,"activeCount":8},[],{"trials":3620,"activeCount":8},[],{"trials":3622,"activeCount":8},[],{"intervention":3608,"totalTrials":20,"cells":3624},{"EARLY_PHASE1":3625,"PHASE1":3627,"PHASE2":3637,"PHASE3":3639,"PHASE4":3641,"NA":3643},{"trials":3626,"activeCount":8},[],{"trials":3628,"activeCount":8},[3629,3633],{"nctId":3603,"briefTitle":3604,"status":123,"phases":3630,"primaryCompletion":932,"completion":932,"start":932,"enrollment":866,"conditions":3631,"interventions":3632},[35],[13],[3596,3608],{"nctId":3610,"briefTitle":3611,"status":123,"phases":3634,"primaryCompletion":2017,"completion":2017,"start":2017,"enrollment":655,"conditions":3635,"interventions":3636},[35],[13],[3596,3608],{"trials":3638,"activeCount":8},[],{"trials":3640,"activeCount":8},[],{"trials":3642,"activeCount":8},[],{"trials":3644,"activeCount":8},[],{"intervention":3646,"totalTrials":20,"cells":3647},"Azithromycin 600 mg",{"EARLY_PHASE1":3648,"PHASE1":3650,"PHASE2":3665,"PHASE3":3667,"PHASE4":3669,"NA":3671},{"trials":3649,"activeCount":8},[],{"trials":3651,"activeCount":8},[3652,3659],{"nctId":3653,"briefTitle":3654,"status":123,"phases":3655,"primaryCompletion":2017,"completion":2017,"start":1220,"enrollment":655,"conditions":3656,"interventions":3657},"NCT00834132","Azithromycin 600 Mg Tablets, Fed",[35],[13],[3646,3658],"Zithromax® 600 mg",{"nctId":3660,"briefTitle":3661,"status":123,"phases":3662,"primaryCompletion":932,"completion":932,"start":933,"enrollment":632,"conditions":3663,"interventions":3664},"NCT00834756","Azithromycin 600 Mg Tablets, Fasting",[35],[13],[3646,3658],{"trials":3666,"activeCount":8},[],{"trials":3668,"activeCount":8},[],{"trials":3670,"activeCount":8},[],{"trials":3672,"activeCount":8},[],{"intervention":3658,"totalTrials":20,"cells":3674},{"EARLY_PHASE1":3675,"PHASE1":3677,"PHASE2":3687,"PHASE3":3689,"PHASE4":3691,"NA":3693},{"trials":3676,"activeCount":8},[],{"trials":3678,"activeCount":8},[3679,3683],{"nctId":3653,"briefTitle":3654,"status":123,"phases":3680,"primaryCompletion":2017,"completion":2017,"start":1220,"enrollment":655,"conditions":3681,"interventions":3682},[35],[13],[3646,3658],{"nctId":3660,"briefTitle":3661,"status":123,"phases":3684,"primaryCompletion":932,"completion":932,"start":933,"enrollment":632,"conditions":3685,"interventions":3686},[35],[13],[3646,3658],{"trials":3688,"activeCount":8},[],{"trials":3690,"activeCount":8},[],{"trials":3692,"activeCount":8},[],{"trials":3694,"activeCount":8},[],{"intervention":3696,"totalTrials":20,"cells":3697},"Ursodiol",{"EARLY_PHASE1":3698,"PHASE1":3700,"PHASE2":3716,"PHASE3":3718,"PHASE4":3720,"NA":3722},{"trials":3699,"activeCount":8},[],{"trials":3701,"activeCount":8},[3702,3709],{"nctId":3703,"briefTitle":3704,"status":123,"phases":3705,"primaryCompletion":739,"completion":739,"start":1005,"enrollment":2355,"conditions":3706,"interventions":3707},"NCT00909610","Ursodiol Tablets 500 mg Under Fasting Conditions",[35],[13],[3696,3708],"Urso Forte™",{"nctId":3710,"briefTitle":3711,"status":123,"phases":3712,"primaryCompletion":530,"completion":530,"start":663,"enrollment":3713,"conditions":3714,"interventions":3715},"NCT00909753","Ursodiol 500 mg Tablets Under Fed Conditions",[35],92,[13],[3696,3708],{"trials":3717,"activeCount":8},[],{"trials":3719,"activeCount":8},[],{"trials":3721,"activeCount":8},[],{"trials":3723,"activeCount":8},[],{"intervention":3708,"totalTrials":20,"cells":3725},{"EARLY_PHASE1":3726,"PHASE1":3728,"PHASE2":3738,"PHASE3":3740,"PHASE4":3742,"NA":3744},{"trials":3727,"activeCount":8},[],{"trials":3729,"activeCount":8},[3730,3734],{"nctId":3703,"briefTitle":3704,"status":123,"phases":3731,"primaryCompletion":739,"completion":739,"start":1005,"enrollment":2355,"conditions":3732,"interventions":3733},[35],[13],[3696,3708],{"nctId":3710,"briefTitle":3711,"status":123,"phases":3735,"primaryCompletion":530,"completion":530,"start":663,"enrollment":3713,"conditions":3736,"interventions":3737},[35],[13],[3696,3708],{"trials":3739,"activeCount":8},[],{"trials":3741,"activeCount":8},[],{"trials":3743,"activeCount":8},[],{"trials":3745,"activeCount":8},[],{"intervention":3747,"totalTrials":20,"cells":3748},"Zoloft® 100 mg",{"EARLY_PHASE1":3749,"PHASE1":3751,"PHASE2":3766,"PHASE3":3768,"PHASE4":3770,"NA":3772},{"trials":3750,"activeCount":8},[],{"trials":3752,"activeCount":8},[3753,3760],{"nctId":3754,"briefTitle":3755,"status":123,"phases":3756,"primaryCompletion":1211,"completion":1211,"start":2868,"enrollment":934,"conditions":3757,"interventions":3758},"NCT00836667","Sertraline Hydrochloride 100 mg Tablets, Fed",[35],[13],[3747,3759],"Sertraline hydrochloride 100 mg",{"nctId":3761,"briefTitle":3762,"status":123,"phases":3763,"primaryCompletion":1211,"completion":1211,"start":2868,"enrollment":655,"conditions":3764,"interventions":3765},"NCT00836849","Sertraline Hydrochloride 100 mg Tablets, Fasting",[35],[13],[3747,3759],{"trials":3767,"activeCount":8},[],{"trials":3769,"activeCount":8},[],{"trials":3771,"activeCount":8},[],{"trials":3773,"activeCount":8},[],{"intervention":3759,"totalTrials":20,"cells":3775},{"EARLY_PHASE1":3776,"PHASE1":3778,"PHASE2":3788,"PHASE3":3790,"PHASE4":3792,"NA":3794},{"trials":3777,"activeCount":8},[],{"trials":3779,"activeCount":8},[3780,3784],{"nctId":3754,"briefTitle":3755,"status":123,"phases":3781,"primaryCompletion":1211,"completion":1211,"start":2868,"enrollment":934,"conditions":3782,"interventions":3783},[35],[13],[3747,3759],{"nctId":3761,"briefTitle":3762,"status":123,"phases":3785,"primaryCompletion":1211,"completion":1211,"start":2868,"enrollment":655,"conditions":3786,"interventions":3787},[35],[13],[3747,3759],{"trials":3789,"activeCount":8},[],{"trials":3791,"activeCount":8},[],{"trials":3793,"activeCount":8},[],{"trials":3795,"activeCount":8},[],{"intervention":1000,"totalTrials":25,"cells":3797},{"EARLY_PHASE1":3798,"PHASE1":3800,"PHASE2":3806,"PHASE3":3808,"PHASE4":3810,"NA":3812},{"trials":3799,"activeCount":8},[],{"trials":3801,"activeCount":8},[3802],{"nctId":993,"briefTitle":994,"status":123,"phases":3803,"primaryCompletion":996,"completion":996,"start":997,"enrollment":632,"conditions":3804,"interventions":3805},[35],[13],[986,1000],{"trials":3807,"activeCount":8},[],{"trials":3809,"activeCount":8},[],{"trials":3811,"activeCount":8},[],{"trials":3813,"activeCount":8},[],{"intervention":3815,"totalTrials":25,"cells":3816},"Cilostazol 50 mg",{"EARLY_PHASE1":3817,"PHASE1":3819,"PHASE2":3828,"PHASE3":3830,"PHASE4":3832,"NA":3834},{"trials":3818,"activeCount":8},[],{"trials":3820,"activeCount":8},[3821],{"nctId":3822,"briefTitle":3823,"status":123,"phases":3824,"primaryCompletion":1758,"completion":1758,"start":1758,"enrollment":752,"conditions":3825,"interventions":3826},"NCT00839930","Cilostazol 50 mg Tablets Under Fasting Conditions",[35],[13],[3815,3827],"Pletal®",{"trials":3829,"activeCount":8},[],{"trials":3831,"activeCount":8},[],{"trials":3833,"activeCount":8},[],{"trials":3835,"activeCount":8},[],{"intervention":3827,"totalTrials":25,"cells":3837},{"EARLY_PHASE1":3838,"PHASE1":3840,"PHASE2":3846,"PHASE3":3848,"PHASE4":3850,"NA":3852},{"trials":3839,"activeCount":8},[],{"trials":3841,"activeCount":8},[3842],{"nctId":3822,"briefTitle":3823,"status":123,"phases":3843,"primaryCompletion":1758,"completion":1758,"start":1758,"enrollment":752,"conditions":3844,"interventions":3845},[35],[13],[3815,3827],{"trials":3847,"activeCount":8},[],{"trials":3849,"activeCount":8},[],{"trials":3851,"activeCount":8},[],{"trials":3853,"activeCount":8},[],{"intervention":3855,"totalTrials":25,"cells":3856},"Adapalene",{"EARLY_PHASE1":3857,"PHASE1":3859,"PHASE2":3870,"PHASE3":3872,"PHASE4":3874,"NA":3876},{"trials":3858,"activeCount":8},[],{"trials":3860,"activeCount":8},[3861],{"nctId":3862,"briefTitle":3863,"status":123,"phases":3864,"primaryCompletion":3865,"completion":3865,"start":622,"enrollment":3866,"conditions":3867,"interventions":3868},"NCT01182636","Bioequivalence of Adapalene Topical Gel in Patients With Acne Vulgaris",[35],"2008-04",601,[19],[3855,3869],"Differin®",{"trials":3871,"activeCount":8},[],{"trials":3873,"activeCount":8},[],{"trials":3875,"activeCount":8},[],{"trials":3877,"activeCount":8},[],{"intervention":3869,"totalTrials":25,"cells":3879},{"EARLY_PHASE1":3880,"PHASE1":3882,"PHASE2":3888,"PHASE3":3890,"PHASE4":3892,"NA":3894},{"trials":3881,"activeCount":8},[],{"trials":3883,"activeCount":8},[3884],{"nctId":3862,"briefTitle":3863,"status":123,"phases":3885,"primaryCompletion":3865,"completion":3865,"start":622,"enrollment":3866,"conditions":3886,"interventions":3887},[35],[19],[3855,3869],{"trials":3889,"activeCount":8},[],{"trials":3891,"activeCount":8},[],{"trials":3893,"activeCount":8},[],{"trials":3895,"activeCount":8},[],{"intervention":1215,"totalTrials":25,"cells":3897},{"EARLY_PHASE1":3898,"PHASE1":3900,"PHASE2":3906,"PHASE3":3908,"PHASE4":3910,"NA":3912},{"trials":3899,"activeCount":8},[],{"trials":3901,"activeCount":8},[3902],{"nctId":1207,"briefTitle":1208,"status":123,"phases":3903,"primaryCompletion":1210,"completion":1210,"start":1211,"enrollment":1212,"conditions":3904,"interventions":3905},[35],[13],[1215,1200],{"trials":3907,"activeCount":8},[],{"trials":3909,"activeCount":8},[],{"trials":3911,"activeCount":8},[],{"trials":3913,"activeCount":8},[],{"intervention":3915,"totalTrials":25,"cells":3916},"Pravastatin sodium 80 mg",{"EARLY_PHASE1":3917,"PHASE1":3919,"PHASE2":3928,"PHASE3":3930,"PHASE4":3932,"NA":3934},{"trials":3918,"activeCount":8},[],{"trials":3920,"activeCount":8},[3921],{"nctId":3922,"briefTitle":3923,"status":123,"phases":3924,"primaryCompletion":1921,"completion":1921,"start":1921,"enrollment":531,"conditions":3925,"interventions":3926},"NCT00830258","Pravastatin Sodium 80 mg Tablets Under Fasting Conditions",[35],[13],[3915,3927],"Pravachol® 80 mg",{"trials":3929,"activeCount":8},[],{"trials":3931,"activeCount":8},[],{"trials":3933,"activeCount":8},[],{"trials":3935,"activeCount":8},[],{"intervention":3927,"totalTrials":25,"cells":3937},{"EARLY_PHASE1":3938,"PHASE1":3940,"PHASE2":3946,"PHASE3":3948,"PHASE4":3950,"NA":3952},{"trials":3939,"activeCount":8},[],{"trials":3941,"activeCount":8},[3942],{"nctId":3922,"briefTitle":3923,"status":123,"phases":3943,"primaryCompletion":1921,"completion":1921,"start":1921,"enrollment":531,"conditions":3944,"interventions":3945},[35],[13],[3915,3927],{"trials":3947,"activeCount":8},[],{"trials":3949,"activeCount":8},[],{"trials":3951,"activeCount":8},[],{"trials":3953,"activeCount":8},[],{"intervention":3955,"totalTrials":25,"cells":3956},"cefprozil",{"EARLY_PHASE1":3957,"PHASE1":3959,"PHASE2":3969,"PHASE3":3971,"PHASE4":3973,"NA":3975},{"trials":3958,"activeCount":8},[],{"trials":3960,"activeCount":8},[3961],{"nctId":3962,"briefTitle":3963,"status":123,"phases":3964,"primaryCompletion":654,"completion":654,"start":654,"enrollment":3965,"conditions":3966,"interventions":3967},"NCT00840866","Cefprozil 500 mg Tablets Under Fed Conditions",[35],39,[13],[3955,3968],"Cefzil®",{"trials":3970,"activeCount":8},[],{"trials":3972,"activeCount":8},[],{"trials":3974,"activeCount":8},[],{"trials":3976,"activeCount":8},[],{"intervention":3968,"totalTrials":25,"cells":3978},{"EARLY_PHASE1":3979,"PHASE1":3981,"PHASE2":3987,"PHASE3":3989,"PHASE4":3991,"NA":3993},{"trials":3980,"activeCount":8},[],{"trials":3982,"activeCount":8},[3983],{"nctId":3962,"briefTitle":3963,"status":123,"phases":3984,"primaryCompletion":654,"completion":654,"start":654,"enrollment":3965,"conditions":3985,"interventions":3986},[35],[13],[3955,3968],{"trials":3988,"activeCount":8},[],{"trials":3990,"activeCount":8},[],{"trials":3992,"activeCount":8},[],{"trials":3994,"activeCount":8},[],{"intervention":3996,"totalTrials":25,"cells":3997},"Topiramate",{"EARLY_PHASE1":3998,"PHASE1":4000,"PHASE2":4009,"PHASE3":4011,"PHASE4":4013,"NA":4015},{"trials":3999,"activeCount":8},[],{"trials":4001,"activeCount":8},[4002],{"nctId":4003,"briefTitle":4004,"status":123,"phases":4005,"primaryCompletion":1245,"completion":1245,"start":1245,"enrollment":752,"conditions":4006,"interventions":4007},"NCT00905606","Topiramate 25 mg Tablets Under Fasting Conditions",[35],[13],[3996,4008],"Topamax®",{"trials":4010,"activeCount":8},[],{"trials":4012,"activeCount":8},[],{"trials":4014,"activeCount":8},[],{"trials":4016,"activeCount":8},[],{"intervention":4008,"totalTrials":25,"cells":4018},{"EARLY_PHASE1":4019,"PHASE1":4021,"PHASE2":4027,"PHASE3":4029,"PHASE4":4031,"NA":4033},{"trials":4020,"activeCount":8},[],{"trials":4022,"activeCount":8},[4023],{"nctId":4003,"briefTitle":4004,"status":123,"phases":4024,"primaryCompletion":1245,"completion":1245,"start":1245,"enrollment":752,"conditions":4025,"interventions":4026},[35],[13],[3996,4008],{"trials":4028,"activeCount":8},[],{"trials":4030,"activeCount":8},[],{"trials":4032,"activeCount":8},[],{"trials":4034,"activeCount":8},[],{"intervention":2227,"totalTrials":25,"cells":4036},{"EARLY_PHASE1":4037,"PHASE1":4039,"PHASE2":4045,"PHASE3":4047,"PHASE4":4049,"NA":4051},{"trials":4038,"activeCount":8},[],{"trials":4040,"activeCount":8},[4041],{"nctId":2222,"briefTitle":2223,"status":123,"phases":4042,"primaryCompletion":2017,"completion":2017,"start":2017,"enrollment":664,"conditions":4043,"interventions":4044},[35],[13],[2215,2227],{"trials":4046,"activeCount":8},[],{"trials":4048,"activeCount":8},[],{"trials":4050,"activeCount":8},[],{"trials":4052,"activeCount":8},[],{"intervention":2409,"totalTrials":25,"cells":4054},{"EARLY_PHASE1":4055,"PHASE1":4057,"PHASE2":4063,"PHASE3":4065,"PHASE4":4067,"NA":4069},{"trials":4056,"activeCount":8},[],{"trials":4058,"activeCount":8},[4059],{"nctId":2403,"briefTitle":2404,"status":123,"phases":4060,"primaryCompletion":1220,"completion":1220,"start":1221,"enrollment":2406,"conditions":4061,"interventions":4062},[35],[13],[2396,2409],{"trials":4064,"activeCount":8},[],{"trials":4066,"activeCount":8},[],{"trials":4068,"activeCount":8},[],{"trials":4070,"activeCount":8},[],{"intervention":2489,"totalTrials":25,"cells":4072},{"EARLY_PHASE1":4073,"PHASE1":4075,"PHASE2":4081,"PHASE3":4083,"PHASE4":4085,"NA":4087},{"trials":4074,"activeCount":8},[],{"trials":4076,"activeCount":8},[4077],{"nctId":2484,"briefTitle":2485,"status":123,"phases":4078,"primaryCompletion":1810,"completion":1810,"start":654,"enrollment":1503,"conditions":4079,"interventions":4080},[35],[13],[2477,2489],{"trials":4082,"activeCount":8},[],{"trials":4084,"activeCount":8},[],{"trials":4086,"activeCount":8},[],{"trials":4088,"activeCount":8},[],{"intervention":2724,"totalTrials":25,"cells":4090},{"EARLY_PHASE1":4091,"PHASE1":4093,"PHASE2":4099,"PHASE3":4101,"PHASE4":4103,"NA":4105},{"trials":4092,"activeCount":8},[],{"trials":4094,"activeCount":8},[4095],{"nctId":2719,"briefTitle":2720,"status":123,"phases":4096,"primaryCompletion":1758,"completion":1758,"start":874,"enrollment":2406,"conditions":4097,"interventions":4098},[35],[13],[2712,2724],{"trials":4100,"activeCount":8},[],{"trials":4102,"activeCount":8},[],{"trials":4104,"activeCount":8},[],{"trials":4106,"activeCount":8},[],{"intervention":2833,"totalTrials":25,"cells":4108},{"EARLY_PHASE1":4109,"PHASE1":4111,"PHASE2":4117,"PHASE3":4119,"PHASE4":4121,"NA":4123},{"trials":4110,"activeCount":8},[],{"trials":4112,"activeCount":8},[4113],{"nctId":2826,"briefTitle":2827,"status":123,"phases":4114,"primaryCompletion":2829,"completion":2829,"start":2829,"enrollment":2830,"conditions":4115,"interventions":4116},[35],[13],[2833,2819],{"trials":4118,"activeCount":8},[],{"trials":4120,"activeCount":8},[],{"trials":4122,"activeCount":8},[],{"trials":4124,"activeCount":8},[],{"intervention":4126,"totalTrials":25,"cells":4127},"Topiramate 2 x 25 mg",{"EARLY_PHASE1":4128,"PHASE1":4130,"PHASE2":4139,"PHASE3":4141,"PHASE4":4143,"NA":4145},{"trials":4129,"activeCount":8},[],{"trials":4131,"activeCount":8},[4132],{"nctId":4133,"briefTitle":4134,"status":123,"phases":4135,"primaryCompletion":1245,"completion":1245,"start":1245,"enrollment":655,"conditions":4136,"interventions":4137},"NCT00905567","Topiramate 25 mg Tablets Under Fed Conditions",[35],[13],[4126,4138],"Topamax® Tablet 2 x 25 mg",{"trials":4140,"activeCount":8},[],{"trials":4142,"activeCount":8},[],{"trials":4144,"activeCount":8},[],{"trials":4146,"activeCount":8},[],{"intervention":4138,"totalTrials":25,"cells":4148},{"EARLY_PHASE1":4149,"PHASE1":4151,"PHASE2":4157,"PHASE3":4159,"PHASE4":4161,"NA":4163},{"trials":4150,"activeCount":8},[],{"trials":4152,"activeCount":8},[4153],{"nctId":4133,"briefTitle":4134,"status":123,"phases":4154,"primaryCompletion":1245,"completion":1245,"start":1245,"enrollment":655,"conditions":4155,"interventions":4156},[35],[13],[4126,4138],{"trials":4158,"activeCount":8},[],{"trials":4160,"activeCount":8},[],{"trials":4162,"activeCount":8},[],{"trials":4164,"activeCount":8},[],{"intervention":4166,"totalTrials":25,"cells":4167},"Cilostazol 100 mg",{"EARLY_PHASE1":4168,"PHASE1":4170,"PHASE2":4179,"PHASE3":4181,"PHASE4":4183,"NA":4185},{"trials":4169,"activeCount":8},[],{"trials":4171,"activeCount":8},[4172],{"nctId":4173,"briefTitle":4174,"status":123,"phases":4175,"primaryCompletion":1809,"completion":1809,"start":1809,"enrollment":632,"conditions":4176,"interventions":4177},"NCT00838630","Cilostazol 100 mg Tablet Formulations Under Fasting Conditions",[35],[13],[4166,4178],"Pletal® 100 mg",{"trials":4180,"activeCount":8},[],{"trials":4182,"activeCount":8},[],{"trials":4184,"activeCount":8},[],{"trials":4186,"activeCount":8},[],{"intervention":4178,"totalTrials":25,"cells":4188},{"EARLY_PHASE1":4189,"PHASE1":4191,"PHASE2":4197,"PHASE3":4199,"PHASE4":4201,"NA":4203},{"trials":4190,"activeCount":8},[],{"trials":4192,"activeCount":8},[4193],{"nctId":4173,"briefTitle":4174,"status":123,"phases":4194,"primaryCompletion":1809,"completion":1809,"start":1809,"enrollment":632,"conditions":4195,"interventions":4196},[35],[13],[4166,4178],{"trials":4198,"activeCount":8},[],{"trials":4200,"activeCount":8},[],{"trials":4202,"activeCount":8},[],{"trials":4204,"activeCount":8},[],{"intervention":1008,"totalTrials":25,"cells":4206},{"EARLY_PHASE1":4207,"PHASE1":4209,"PHASE2":4215,"PHASE3":4217,"PHASE4":4219,"NA":4221},{"trials":4208,"activeCount":8},[],{"trials":4210,"activeCount":8},[4211],{"nctId":1002,"briefTitle":1003,"status":123,"phases":4212,"primaryCompletion":739,"completion":739,"start":1005,"enrollment":632,"conditions":4213,"interventions":4214},[35],[27],[986,1008],{"trials":4216,"activeCount":8},[],{"trials":4218,"activeCount":8},[],{"trials":4220,"activeCount":8},[],{"trials":4222,"activeCount":8},[],{"intervention":4224,"totalTrials":25,"cells":4225},"Topiramate 25 mg",{"EARLY_PHASE1":4226,"PHASE1":4228,"PHASE2":4237,"PHASE3":4239,"PHASE4":4241,"NA":4243},{"trials":4227,"activeCount":8},[],{"trials":4229,"activeCount":8},[4230],{"nctId":4231,"briefTitle":4232,"status":123,"phases":4233,"primaryCompletion":1220,"completion":1220,"start":1221,"enrollment":655,"conditions":4234,"interventions":4235},"NCT00905346","Topiramate 25 mg Capsule Mixed With Applesauce Under Fasting Conditions",[35],[13],[4224,4236],"Topamax® 25 mg",{"trials":4238,"activeCount":8},[],{"trials":4240,"activeCount":8},[],{"trials":4242,"activeCount":8},[],{"trials":4244,"activeCount":8},[],{"intervention":4236,"totalTrials":25,"cells":4246},{"EARLY_PHASE1":4247,"PHASE1":4249,"PHASE2":4255,"PHASE3":4257,"PHASE4":4259,"NA":4261},{"trials":4248,"activeCount":8},[],{"trials":4250,"activeCount":8},[4251],{"nctId":4231,"briefTitle":4232,"status":123,"phases":4252,"primaryCompletion":1220,"completion":1220,"start":1221,"enrollment":655,"conditions":4253,"interventions":4254},[35],[13],[4224,4236],{"trials":4256,"activeCount":8},[],{"trials":4258,"activeCount":8},[],{"trials":4260,"activeCount":8},[],{"trials":4262,"activeCount":8},[],{"intervention":4264,"totalTrials":25,"cells":4265},"medroxyprogesterone acetate",{"EARLY_PHASE1":4266,"PHASE1":4268,"PHASE2":4277,"PHASE3":4279,"PHASE4":4281,"NA":4283},{"trials":4267,"activeCount":8},[],{"trials":4269,"activeCount":8},[4270],{"nctId":4271,"briefTitle":4272,"status":123,"phases":4273,"primaryCompletion":933,"completion":933,"start":1211,"enrollment":4274,"conditions":4275,"interventions":4276},"NCT00830414","Medroxyprogesterone Acetate Injection 150 mg\u002F1 mL in Postmenopausal Women",[35],124,[13],[4264,4264],{"trials":4278,"activeCount":8},[],{"trials":4280,"activeCount":8},[],{"trials":4282,"activeCount":8},[],{"trials":4284,"activeCount":8},[],{"intervention":4286,"totalTrials":25,"cells":4287},"Rowasa® 4 gm\u002F60 mL Rectal Enema",{"EARLY_PHASE1":4288,"PHASE1":4290,"PHASE2":4300,"PHASE3":4302,"PHASE4":4304,"NA":4306},{"trials":4289,"activeCount":8},[],{"trials":4291,"activeCount":8},[4292],{"nctId":4293,"briefTitle":4294,"status":123,"phases":4295,"primaryCompletion":4296,"completion":4296,"start":2121,"enrollment":4297,"conditions":4298,"interventions":4299},"NCT00840203","Mesalamine 4 gm\u002F60 mL Rectal Enema",[35],"2003-06",72,[13],[4286,4294],{"trials":4301,"activeCount":8},[],{"trials":4303,"activeCount":8},[],{"trials":4305,"activeCount":8},[],{"trials":4307,"activeCount":8},[],{"intervention":4294,"totalTrials":25,"cells":4309},{"EARLY_PHASE1":4310,"PHASE1":4312,"PHASE2":4318,"PHASE3":4320,"PHASE4":4322,"NA":4324},{"trials":4311,"activeCount":8},[],{"trials":4313,"activeCount":8},[4314],{"nctId":4293,"briefTitle":4294,"status":123,"phases":4315,"primaryCompletion":4296,"completion":4296,"start":2121,"enrollment":4297,"conditions":4316,"interventions":4317},[35],[13],[4286,4294],{"trials":4319,"activeCount":8},[],{"trials":4321,"activeCount":8},[],{"trials":4323,"activeCount":8},[],{"trials":4325,"activeCount":8},[],{"intervention":3328,"totalTrials":25,"cells":4327},{"EARLY_PHASE1":4328,"PHASE1":4330,"PHASE2":4336,"PHASE3":4338,"PHASE4":4340,"NA":4342},{"trials":4329,"activeCount":8},[],{"trials":4331,"activeCount":8},[4332],{"nctId":3323,"briefTitle":3324,"status":123,"phases":4333,"primaryCompletion":1911,"completion":1911,"start":1911,"enrollment":1325,"conditions":4334,"interventions":4335},[35],[13],[3316,3328],{"trials":4337,"activeCount":8},[],{"trials":4339,"activeCount":8},[],{"trials":4341,"activeCount":8},[],{"trials":4343,"activeCount":8},[],{"intervention":4345,"totalTrials":25,"cells":4346},"Bupropion HCl",{"EARLY_PHASE1":4347,"PHASE1":4349,"PHASE2":4359,"PHASE3":4361,"PHASE4":4363,"NA":4365},{"trials":4348,"activeCount":8},[],{"trials":4350,"activeCount":8},[4351],{"nctId":4352,"briefTitle":4353,"status":79,"phases":4354,"start":4355,"enrollment":4356,"conditions":4357,"interventions":4358},"NCT01046214","Bupropion Hydrochloride 300 mg Extended Release Tablets Under Fasting Conditions",[35],"2010-01",8,[31],[4345,4345],{"trials":4360,"activeCount":8},[],{"trials":4362,"activeCount":8},[],{"trials":4364,"activeCount":8},[],{"trials":4366,"activeCount":8},[],{"intervention":3335,"totalTrials":25,"cells":4368},{"EARLY_PHASE1":4369,"PHASE1":4371,"PHASE2":4377,"PHASE3":4379,"PHASE4":4381,"NA":4383},{"trials":4370,"activeCount":8},[],{"trials":4372,"activeCount":8},[4373],{"nctId":3330,"briefTitle":3331,"status":123,"phases":4374,"primaryCompletion":2969,"completion":2969,"start":1911,"enrollment":1325,"conditions":4375,"interventions":4376},[35],[13],[3316,3335],{"trials":4378,"activeCount":8},[],{"trials":4380,"activeCount":8},[],{"trials":4382,"activeCount":8},[],{"trials":4384,"activeCount":8},[],{"intervention":2809,"totalTrials":25,"cells":4386},{"EARLY_PHASE1":4387,"PHASE1":4389,"PHASE2":4395,"PHASE3":4397,"PHASE4":4399,"NA":4401},{"trials":4388,"activeCount":8},[],{"trials":4390,"activeCount":8},[4391],{"nctId":2804,"briefTitle":2805,"status":123,"phases":4392,"primaryCompletion":729,"completion":729,"start":730,"enrollment":2355,"conditions":4393,"interventions":4394},[35],[13],[2809,2790],{"trials":4396,"activeCount":8},[],{"trials":4398,"activeCount":8},[],{"trials":4400,"activeCount":8},[],{"trials":4402,"activeCount":8},[],{"intervention":2497,"totalTrials":25,"cells":4404},{"EARLY_PHASE1":4405,"PHASE1":4407,"PHASE2":4413,"PHASE3":4415,"PHASE4":4417,"NA":4419},{"trials":4406,"activeCount":8},[],{"trials":4408,"activeCount":8},[4409],{"nctId":2491,"briefTitle":2492,"status":123,"phases":4410,"primaryCompletion":1810,"completion":1810,"start":654,"enrollment":2494,"conditions":4411,"interventions":4412},[35],[13],[2477,2497],{"trials":4414,"activeCount":8},[],{"trials":4416,"activeCount":8},[],{"trials":4418,"activeCount":8},[],{"trials":4420,"activeCount":8},[],{"intervention":4422,"totalTrials":25,"cells":4423},"Cefzil® 500 mg",{"EARLY_PHASE1":4424,"PHASE1":4426,"PHASE2":4435,"PHASE3":4437,"PHASE4":4439,"NA":4441},{"trials":4425,"activeCount":8},[],{"trials":4427,"activeCount":8},[4428],{"nctId":4429,"briefTitle":4430,"status":123,"phases":4431,"primaryCompletion":654,"completion":654,"start":654,"enrollment":455,"conditions":4432,"interventions":4433},"NCT00840281","Cefprozil 500 mg Tablets Under Fasting Conditions",[35],[13],[4422,4434],"Cefprozil 500 mg",{"trials":4436,"activeCount":8},[],{"trials":4438,"activeCount":8},[],{"trials":4440,"activeCount":8},[],{"trials":4442,"activeCount":8},[],{"intervention":4434,"totalTrials":25,"cells":4444},{"EARLY_PHASE1":4445,"PHASE1":4447,"PHASE2":4453,"PHASE3":4455,"PHASE4":4457,"NA":4459},{"trials":4446,"activeCount":8},[],{"trials":4448,"activeCount":8},[4449],{"nctId":4429,"briefTitle":4430,"status":123,"phases":4450,"primaryCompletion":654,"completion":654,"start":654,"enrollment":455,"conditions":4451,"interventions":4452},[35],[13],[4422,4434],{"trials":4454,"activeCount":8},[],{"trials":4456,"activeCount":8},[],{"trials":4458,"activeCount":8},[],{"trials":4460,"activeCount":8},[],{"intervention":1225,"totalTrials":25,"cells":4462},{"EARLY_PHASE1":4463,"PHASE1":4465,"PHASE2":4471,"PHASE3":4473,"PHASE4":4475,"NA":4477},{"trials":4464,"activeCount":8},[],{"trials":4466,"activeCount":8},[4467],{"nctId":1217,"briefTitle":1218,"status":123,"phases":4468,"primaryCompletion":1220,"completion":1220,"start":1221,"enrollment":1222,"conditions":4469,"interventions":4470},[35],[13],[1200,1225],{"trials":4472,"activeCount":8},[],{"trials":4474,"activeCount":8},[],{"trials":4476,"activeCount":8},[],{"trials":4478,"activeCount":8},[],{"intervention":2234,"totalTrials":25,"cells":4480},{"EARLY_PHASE1":4481,"PHASE1":4483,"PHASE2":4489,"PHASE3":4491,"PHASE4":4493,"NA":4495},{"trials":4482,"activeCount":8},[],{"trials":4484,"activeCount":8},[4485],{"nctId":2229,"briefTitle":2230,"status":123,"phases":4486,"primaryCompletion":2017,"completion":2017,"start":2017,"enrollment":664,"conditions":4487,"interventions":4488},[35],[13],[2215,2234],{"trials":4490,"activeCount":8},[],{"trials":4492,"activeCount":8},[],{"trials":4494,"activeCount":8},[],{"trials":4496,"activeCount":8},[],{"intervention":4498,"totalTrials":25,"cells":4499},"Alendronate Sodium Tablets 70mg",{"EARLY_PHASE1":4500,"PHASE1":4502,"PHASE2":4514,"PHASE3":4516,"PHASE4":4518,"NA":4520},{"trials":4501,"activeCount":8},[],{"trials":4503,"activeCount":8},[4504],{"nctId":4505,"briefTitle":4506,"status":123,"phases":4507,"primaryCompletion":4508,"completion":4508,"start":4509,"enrollment":4510,"conditions":4511,"interventions":4512},"NCT00835406","Alendronate Sodium 70 mg Tablet Versus Fosamax® Under Fasting Conditions.",[35],"2000-07","2000-06",140,[13],[4498,4513],"Fosamax® Tablets 70mg",{"trials":4515,"activeCount":8},[],{"trials":4517,"activeCount":8},[],{"trials":4519,"activeCount":8},[],{"trials":4521,"activeCount":8},[],{"intervention":4513,"totalTrials":25,"cells":4523},{"EARLY_PHASE1":4524,"PHASE1":4526,"PHASE2":4532,"PHASE3":4534,"PHASE4":4536,"NA":4538},{"trials":4525,"activeCount":8},[],{"trials":4527,"activeCount":8},[4528],{"nctId":4505,"briefTitle":4506,"status":123,"phases":4529,"primaryCompletion":4508,"completion":4508,"start":4509,"enrollment":4510,"conditions":4530,"interventions":4531},[35],[13],[4498,4513],{"trials":4533,"activeCount":8},[],{"trials":4535,"activeCount":8},[],{"trials":4537,"activeCount":8},[],{"trials":4539,"activeCount":8},[],{"intervention":4541,"totalTrials":25,"cells":4542},"Desmopressin Acetate 0.2 mg",{"EARLY_PHASE1":4543,"PHASE1":4545,"PHASE2":4554,"PHASE3":4556,"PHASE4":4558,"NA":4560},{"trials":4544,"activeCount":8},[],{"trials":4546,"activeCount":8},[4547],{"nctId":4548,"briefTitle":4549,"status":123,"phases":4550,"primaryCompletion":865,"completion":865,"start":2436,"enrollment":664,"conditions":4551,"interventions":4552},"NCT00835211","Desmopressin Acetate 0.2 mg Tablets, Fasting",[35],[13],[4541,4553],"DDAVP® 0.2 mg",{"trials":4555,"activeCount":8},[],{"trials":4557,"activeCount":8},[],{"trials":4559,"activeCount":8},[],{"trials":4561,"activeCount":8},[],{"intervention":4553,"totalTrials":25,"cells":4563},{"EARLY_PHASE1":4564,"PHASE1":4566,"PHASE2":4572,"PHASE3":4574,"PHASE4":4576,"NA":4578},{"trials":4565,"activeCount":8},[],{"trials":4567,"activeCount":8},[4568],{"nctId":4548,"briefTitle":4549,"status":123,"phases":4569,"primaryCompletion":865,"completion":865,"start":2436,"enrollment":664,"conditions":4570,"interventions":4571},[35],[13],[4541,4553],{"trials":4573,"activeCount":8},[],{"trials":4575,"activeCount":8},[],{"trials":4577,"activeCount":8},[],{"trials":4579,"activeCount":8},[],{"intervention":4581,"totalTrials":25,"cells":4582},"Buprenorphine",{"EARLY_PHASE1":4583,"PHASE1":4585,"PHASE2":4594,"PHASE3":4596,"PHASE4":4598,"NA":4600},{"trials":4584,"activeCount":8},[],{"trials":4586,"activeCount":8},[4587],{"nctId":4588,"briefTitle":4589,"status":123,"phases":4590,"primaryCompletion":4591,"completion":4591,"start":631,"enrollment":541,"conditions":4592,"interventions":4593},"NCT01157169","Buprenorphine 8 mg Sublingual Tablets Under Fasting Conditions",[35],"2007-09",[13],[4581,4581],{"trials":4595,"activeCount":8},[],{"trials":4597,"activeCount":8},[],{"trials":4599,"activeCount":8},[],{"trials":4601,"activeCount":8},[],{"intervention":2416,"totalTrials":25,"cells":4603},{"EARLY_PHASE1":4604,"PHASE1":4606,"PHASE2":4612,"PHASE3":4614,"PHASE4":4616,"NA":4618},{"trials":4605,"activeCount":8},[],{"trials":4607,"activeCount":8},[4608],{"nctId":2411,"briefTitle":2412,"status":123,"phases":4609,"primaryCompletion":1221,"completion":1221,"start":1221,"enrollment":1325,"conditions":4610,"interventions":4611},[35],[13],[2396,2416],{"trials":4613,"activeCount":8},[],{"trials":4615,"activeCount":8},[],{"trials":4617,"activeCount":8},[],{"trials":4619,"activeCount":8},[]]